Publications - Nicholas J. Talley, M.D., Ph.D.

Back to research profile

1. Choung RS, Locke GR, Schleck CD, Zinsmeister AR, Talley NJ. Associations between medication use and functional gastrointestinal disorders: a population-based study. Neurogastroenterol Motil. 2013 May; 25(5):413-e298. Epub 2013 Jan 29.
   View PubMed
2. Topazian M, Camilleri M, Enders FT, Clain JE, Gleeson FC, Levy MJ, Rajan E, Nehra V, Dierkhising RA, Collazo-Clavell ML, Talley NJ, Clark MM. Gastric antral injections of botulinum toxin delay gastric emptying but do not reduce body weight. Clin Gastroenterol Hepatol. 2013 Feb; 11(2):145-50.e1. Epub 2012 Oct 09.
   View PubMed
3. Leggett CL, Nelsen EM, Tian J, Schleck CB, Zinsmeister AR, Dunagan KT, Locke GR 3rd, Wang KK, Talley NJ, Iyer PG. Metabolic syndrome as a risk factor for barrett esophagus: a population-based case-control study. Mayo Clin Proc. 2013 Feb; 88(2):157-65.
   View PubMed
4. Flook NW, Moayyedi P, Dent J, Talley NJ, Persson T, Karlson BW, Ruth M. Acid-suppressive therapy with esomeprazole for relief of unexplained chest pain in primary care: a randomized, double-blind, placebo-controlled trial. Am J Gastroenterol. 2013 Jan; 108(1):56-64. Epub 2012 Nov 13.
   View PubMed
5. Choung RS, Locke GR III, Schleck CD, Ziegenfuss JY, Beebe TJ, Zinsmeister AR, Talley NJ. A low response rate does not necessarily indicate non-response bias in gastroenterology survey research: A population-based study. Journal of Public Health (Germany). 2013; 21(1):87-95.
6. Rajan E, Gostout CJ, Aimore Bonin E, Moran EA, Locke RG, Szarka LA, Talley NJ, Deters JL, Miller CA, Knipschield MA, Lurken MS, Stoltz GJ, Bernard CE, Grover M, Farrugia G. Endoscopic full-thickness biopsy of the gastric wall with defect closure by using an endoscopic suturing device: survival porcine study. Gastrointest Endosc. 2012 Nov; 76(5):1014-9.
   View PubMed
7. Saito YA, Larson JJ, Atkinson EJ, Ryu E, Almazar AE, Petersen GM, Talley NJ. The role of 5-HTT LPR and GNbeta3 825C>T polymorphisms and gene-environment interactions in irritable bowel syndrome (IBS). Dig Dis Sci. 2012 Oct; 57(10):2650-7. Epub 2012 Aug 2
   View PubMed
8. Talley NJ. Dietary modification as a treatment for irritable bowel syndrome. Gastroenterol Hepatol (N Y). 2012 Aug; 8(8):552-4.
   View PubMed
9. Lacy BE, Talley NJ, Locke GR 3rd, Bouras EP, DiBaise JK, El-Serag HB, Abraham BP, Howden CW, Moayyedi P, Prather C. Review article: current treatment options and management of functional dyspepsia. Aliment Pharmacol Ther. 2012 Jul; 36(1):3-15. Epub 2012 May 16.
   View PubMed
10. Alexander JA, Jung KW, Arora AS, Enders F, Katzka DA, Kephardt GM, Kita H, Kryzer LA, Romero Y, Smyrk TC, Talley NJ. Swallowed fluticasone improves histologic but not symptomatic response of adults with eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2012 Jul; 10(7):742-749.e1. Epub 2012 Apr 01.
    View PubMed
11. Myasoedova E, Matteson EL, Talley NJ, Crowson CS. Increased incidence and impact of upper and lower gastrointestinal events in patients with rheumatoid arthritis in Olmsted County, Minnesota: a longitudinal population-based study. J Rheumatol. 2012 Jul; 39(7):1355-62. Epub 2012 Apr 01.
    View PubMed
12. Herrick LM, Locke GR 3rd, Zinsmeister AR, Talley NJ. Challenges and lessons learned in conducting comparative-effectiveness trials. Am J Gastroenterol. 2012 May; 107(5):644-9.
    View PubMed
13. Talley NJ, Locke GR 3rd, Herrick LM, Silvernail VM, Prather CM, Lacy BE, DiBaise JK, Howden CW, Brenner DM, Bouras EP, El-Serag HB, Abraham BP, Moayyedi P, Zinsmeister AR. Functional Dyspepsia Treatment Trial (FDTT): a double-blind, randomized, placebo-controlled trial of antidepressants in functional dyspepsia, evaluating symptoms, psychopathology, pathophysiology and pharmacogenetics. Contemp Clin Trials. 2012 May; 33(3):523-33. Epub 2012 Feb 10.
    View PubMed
14. Choung RS, Locke GR 3rd, Rey E, Schleck CD, Baum C, Zinsmeister AR, Talley NJ. Factors associated with persistent and nonpersistent chronic constipation, over 20 years. Clin Gastroenterol Hepatol. 2012 May; 10(5):494-500. Epub 2012 Jan 28.
    View PubMed
15. Lee J, Huprich J, Kujath C, Ravi K, Enders F, Smyrk TC, Katzka DA, Talley NJ, Alexander JA. Esophageal diameter is decreased in some patients with eosinophilic esophagitis and might increase with topical corticosteroid therapy. Clin Gastroenterol Hepatol. 2012 May; 10(5):481-6. Epub 2012 Feb 3.
    View PubMed
16. Choung RS, Locke GR 3rd, Schleck CD, Zinsmeister AR, Talley NJ. Overlap of dyspepsia and gastroesophageal reflux in the general population: one disease or distinct entities? Neurogastroenterol Motil. 2012 Mar; 24(3):229-34, e106. Epub 2011 Dec 12.
    View PubMed
17. Adibi P, Keshteli AH, Esmaillzadeh A, Afshar H, Roohafza H, Bagherian-Sararoudi R, Daghaghzadeh H, Soltanian N, Feinle-Bisset C, Boyce P, Talley NJ. The study on the epidemiology of psychological, alimentary health and nutrition (SEPAHAN): overview of methodology. Journal Of Research In Medical Sciences. 2012 Mar; 17:S292-8.
18. Rey E, Choung RS, Schleck CD, Zinsmeister AR, Talley NJ, Locke GR 3rd. Prevalence of hidden gastroparesis in the community: the gastroparesis "iceberg". J Neurogastroenterol Motil. 2012 Jan; 18(1):34-42. Epub 2012 Jan 16.
    View PubMed
19. Brook RA, Kleinman NL, Choung RS, Smeeding JE, Talley NJ. Excess comorbidity prevalence and cost associated with functional dyspepsia in an employed population. Dig Dis Sci. 2012 Jan; 57(1):109-18. Epub 2011 Jul 13.
    View PubMed
20. Choung RS, Locke GR 3rd, Lee RM, Schleck CD, Zinsmeister AR, Talley NJ. Cyclic vomiting syndrome and functional vomiting in adults: association with cannabinoid use in males. Neurogastroenterol Motil. 2012 Jan; 24(1):20-6, e1. Epub 2011 Sep 27.
    View PubMed
21. Choung RS, Locke GR 3rd, Schleck CD, Zinsmeister AR, Melton LJ 3rd, Talley NJ. Risk of gastroparesis in subjects with type 1 and 2 diabetes in the general population. Am J Gastroenterol. 2012 Jan; 107(1):82-8. Epub 2011 Nov 15.
    View PubMed
22. Tack J, Talley NJ. [In process citation]. Arq Gastroenterol. 2012; 49 Suppl 1:21-7.
    View PubMed
23. Chang JY, Talley NJ, Locke GR 3rd, Katzka DA, Schleck CD, Zinsmeister AR, Dunagan KT, Wu TT, Wang KK, Prasad GA. Population screening for barrett esophagus: a prospective randomized pilot study. Mayo Clin Proc. 2011 Dec; 86(12):1174-80.
    View PubMed
24. van Zanten SV, Wahlqvist P, Talley NJ, Halling K, Vakil N, Lauritsen K, Flook N, Persson T, Bolling-Sternevald E, STARS II Investigators. Randomised clinical trial: the burden of illness of uninvestigated dyspepsia before and after treatment with esomeprazole--results from the STARS II study. Aliment Pharmacol Ther. 2011 Oct; 34(7):714-23. Epub 2011 Aug 17.
    View PubMed
25. Walker MM, Talley NJ. Clinical value of duodenal biopsies--beyond the diagnosis of coeliac disease. Pathol Res Pract. 2011 Sep 15; 207(9):538-44. Epub 2011 Sep 22.
    View PubMed
26. Jung KW, Talley NJ, Romero Y, Katzka DA, Schleck CD, Zinsmeister AR, Dunagan KT, Lutzke LS, Wu TT, Wang KK, Frederickson M, Geno DM, Locke GR, Prasad GA. Epidemiology and natural history of intestinal metaplasia of the gastroesophageal junction and Barrett's esophagus: a population-based study. Am J Gastroenterol. 2011 Aug; 106(8):1447-55; quiz 1456. Epub 2011 Apr 12.
    View PubMed
27. Ravi K, Talley NJ, Smyrk TC, Katzka DA, Kryzer L, Romero Y, Arora AS, Alexander JA. Low grade esophageal eosinophilia in adults: an unrecognized part of the spectrum of eosinophilic esophagitis? Dig Dis Sci. 2011 Jul; 56(7):1981-6. Epub 2011 Feb 06.
    View PubMed
28. Katz KD, Rashtak S, Lahr BD, Melton LJ 3rd, Krause PK, Maggi K, Talley NJ, Murray JA. Screening for celiac disease in a North American population: sequential serology and gastrointestinal symptoms. Am J Gastroenterol. 2011 Jul; 106(7):1333-9. Epub 2011 Mar 01.
    View PubMed
29. Talley NJ. Irritable bowel syndrome: rational therapy. Consultant. 2011 Jun; 51(6):341-7.
30. Achem SR, Almansa C, Krishna M, Heckman MG, Wolfsen HC, Talley NJ, DeVault KR. Oesophageal eosinophilic infiltration in patients with noncardiac chest pain. Aliment Pharmacol Ther. 2011 Jun; 33(11):1194-201. Epub 2011 Apr 05.
    View PubMed
31. Choung RS, Ruff KC, Malhotra A, Herrick L, Locke GR 3rd, Harmsen WS, Zinsmeister AR, Talley NJ, Saito YA. Clinical predictors of small intestinal bacterial overgrowth by duodenal aspirate culture. Aliment Pharmacol Ther. 2011 May; 33(9):1059-67. Epub 2011 Mar 13.
    View PubMed
32. Pittock SJ, Lennon VA, Dege CL, Talley NJ, Locke GR 3rd. Neural autoantibody evaluation in functional gastrointestinal disorders: a population-based case-control study. Dig Dis Sci. 2011 May; 56(5):1452-9. Epub 2010 Dec 23.
    View PubMed
33. Beebe TJ, Ziegenfuss JY, St Sauver JL, Jenkins SM, Haas L, Davern ME, Talley NJ. Health Insurance Portability and Accountability Act (HIPAA) authorization and survey nonresponse bias. Med Care. 2011 Apr; 49(4):365-70.
    View PubMed
34. Wang YR, Talley NJ, Picco MF. Overlap irritable bowel syndrome, inflammatory bowel disease, and diverticular disease. J Clin Gastroenterol. 2011 Apr; 45(Suppl 1):S36-42.
35. Talley NJ, Abreu MT, Achkar JP, Bernstein CN, Dubinsky MC, Hanauer SB, Kane SV, Sandborn WJ, Ullman TA, Moayyedi P, American College of Gastroenterology IBD Task Force. An evidence-based systematic review on medical therapies for inflammatory bowel disease. Am J Gastroenterol. 2011 Apr; 106 Suppl 1:S2-25; quiz S26.
    View PubMed
36. Ford AC, Achkar JP, Khan KJ, Kane SV, Talley NJ, Marshall JK, Moayyedi P. Efficacy of 5-aminosalicylates in ulcerative colitis: systematic review and meta-analysis. Am J Gastroenterol. 2011 Apr; 106(4):601-16. Epub 2011 Mar 15.
    View PubMed
37. Ford AC, Kane SV, Khan KJ, Achkar JP, Talley NJ, Marshall JK, Moayyedi P. Efficacy of 5-aminosalicylates in Crohn's disease: systematic review and meta-analysis. Am J Gastroenterol. 2011 Apr; 106(4):617-29. Epub 2011 Mar 15.
    View PubMed
38. Dinning PG, Jones M, Hunt L, Fuentealba SE, Kalanter J, King DW, Lubowski DZ, Talley NJ, Cook IJ. Factor analysis identifies subgroups of constipation. World J Gastroenterol. 2011 Mar 21; 17(11):1468-74.
    View PubMed
39. Ang D, Talley NJ, Simren M, Janssen P, Boeckxstaens G, Tack J. Review article: endpoints used in functional dyspepsia drug therapy trials. Aliment Pharmacol Ther. 2011 Mar; 33(6):634-49. Epub 2011 Jan 12.
    View PubMed
40. Spergel JM, Book WM, Mays E, Song L, Shah SS, Talley NJ, Bonis PA. Variation in prevalence, diagnostic criteria, and initial management options for eosinophilic gastrointestinal diseases in the United States. J Pediatr Gastroenterol Nutr. 2011 Mar; 52(3):300-6.
    View PubMed
41. Talley NJ. Rumination syndrome. Gastroenterol Hepatol (N Y). 2011 Feb; 7(2):117-8.
    View PubMed
42. Choung RS, Branda ME, Chitkara D, Shah ND, Katusic SK, Locke GR 3rd, Talley NJ. Longitudinal direct medical costs associated with constipation in women. Aliment Pharmacol Ther. 2011 Jan; 33(2):251-60. Epub 2010 Nov 22.
    View PubMed
43. Chang JY, Talley NJ. An update on irritable bowel syndrome: from diagnosis to emerging therapies. Curr Opin Gastroenterol. 2011 Jan; 27(1):72-8.
    View PubMed
44. Jung KW, Gundersen N, Kopacova J, Arora AS, Romero Y, Katzka D, Francis D, Schreiber J, Dierkhising RA, Talley NJ, Smyrk TC, Alexander JA. Occurrence of and risk factors for complications after endoscopic dilation in eosinophilic esophagitis. Gastrointest Endosc. 2011 Jan; 73(1):15-21. Epub 2010 Nov 09.
    View PubMed
45. Choung RS, Shah ND, Chitkara D, Branda ME, Van Tilburg MA, Whitehead WE, Katusic SK, Locke GR 3rd, Talley NJ. Direct medical costs of constipation from childhood to early adulthood: a population-based birth cohort study. J Pediatr Gastroenterol Nutr. 2011 Jan; 52(1):47-54.
    View PubMed
46. Myasoedova E, Talley NJ, Manek NJ, Crowson CS. Prevalence and risk factors of gastrointestinal disorders in patients with rheumatoid arthritis: results from a population-based survey in olmsted county, Minnesota. Gastroenterol Res Pract. 2011; 2011:745829. Epub 2011 Nov 17.
    View PubMed
47. Lacy BE, Talley NJ, Camilleri M. Functional dyspepsia: time to change clinical trial design? Am J Gastroenterol. 2010 Dec; 105(12):2525-9.
    View PubMed
48. Choung RS, Herrick LM, Locke GR 3rd, Zinsmeister AR, Talley NJ. Irritable bowel syndrome and chronic pelvic pain: a population-based study. J Clin Gastroenterol. 2010 Nov-Dec; 44(10):696-701.
    View PubMed
49. Aro P, Ronkainen J, Storskrubb T, Vieth M, Engstrand L, Johansson SE, Bolling-Sternevald E, Bolinder G, Alving K, Talley NJ, Agreus L. Use of tobacco products and gastrointestinal morbidity: an endoscopic population-based study (the Kalixanda study). Eur J Epidemiol. 2010 Oct; 25(10):741-50. Epub 2010 Jul 29.
    View PubMed
50. McElhiney J, Lohse MR, Arora AS, Peloquin JM, Geno DM, Kuntz MM, Enders FB, Fredericksen M, Abdalla AA, Khan Y, Talley NJ, Diehl NN, Beebe TJ, Harris AM, Farrugia G, Graner DE, Murray JA, Locke GR 3rd, Grothe RM, Crowell MD, Francis DL, Grudell AM, The Mayo Dysphagia Questionnaire-30: documentation of reliability and validity of a tool for interventional trials in adults with esophageal disease. Dysphagia. 2010 Sep; 25(3):221-30. Epub 2009 Oct 24.
    View PubMed
51. Chang JY, Choung RS, Lee RM, Locke GR 3rd, Schleck CD, Zinsmeister AR, Smyrk TC, Talley NJ. A shift in the clinical spectrum of eosinophilic gastroenteritis toward the mucosal disease type. Clin Gastroenterol Hepatol. 2010 Aug; 8(8):669-75; quiz e88. Epub 2010 May 06.
    View PubMed
52. Chang JY, Talley NJ. Current and emerging therapies in irritable bowel syndrome: from pathophysiology to treatment. Trends Pharmacol Sci. 2010 Jul; 31(7):326-34. Epub 2010 Jun 01.
    View PubMed
53. Walker MM, Murray JA, Ronkainen J, Aro P, Storskrubb T, D'Amato M, Lahr B, Talley NJ, Agreus L. Detection of celiac disease and lymphocytic enteropathy by parallel serology and histopathology in a population-based study. Gastroenterology. 2010 Jul; 139(1):112-9. Epub 2010 Apr 13.
    View PubMed
54. Brook RA, Kleinman NL, Choung RS, Melkonian AK, Smeeding JE, Talley NJ. Functional dyspepsia impacts absenteeism and direct and indirect costs. Clin Gastroenterol Hepatol. 2010 Jun; 8(6):498-503. Epub 2010 Mar 19.
    View PubMed
55. Gururatsakul M, Holloway RH, Talley NJ, Holtmann GJ. Association between clinical manifestations of complicated and uncomplicated peptic ulcer and visceral sensory dysfunction. J Gastroenterol Hepatol. 2010 Jun; 25(6):1162-9.
    View PubMed
56. Walker MM, Salehian SS, Murray CE, Rajendran A, Hoare JM, Negus R, Powell N, Talley NJ. Implications of eosinophilia in the normal duodenal biopsy - an association with allergy and functional dyspepsia. Aliment Pharmacol Ther. 2010 Jun; 31(11):1229-36. Epub 2010 Mar 04.
    View PubMed
57. Rey E, Locke GR 3rd, Jung HK, Malhotra A, Choung RS, Beebe TJ, Schleck CD, Zinsmeister AR, Talley NJ. Measurement of abdominal symptoms by validated questionnaire: a 3-month recall timeframe as recommended by Rome III is not superior to a 1-year recall timeframe. Aliment Pharmacol Ther. 2010 Jun; 31(11):1237-47. Epub 2010 Mar 06.
    View PubMed
58. Walter SA, Kjellstrom L, Nyhlin H, Talley NJ, Agreus L. Assessment of normal bowel habits in the general adult population: the Popcol study. Scand J Gastroenterol. 2010 May; 45(5):556-66.
    View PubMed
59. Tack J, Talley NJ. Gastroduodenal disorders. Am J Gastroenterol. 2010 Apr; 105(4):757-63.
    View PubMed
60. Saito YA, Petersen GM, Larson JJ, Atkinson EJ, Fridley BL, de Andrade M, Locke GR 3rd, Zimmerman JM, Almazar-Elder AE, Talley NJ. Familial aggregation of irritable bowel syndrome: a family case-control study. Am J Gastroenterol. 2010 Apr; 105(4):833-41. Epub 2010 Mar 16.
    View PubMed
61. Leise MD, Locke GR 3rd, Dierkhising RA, Zinsmeister AR, Reeder GS, Talley NJ. Patients dismissed from the hospital with a diagnosis of noncardiac chest pain: cardiac outcomes and health care utilization. Mayo Clin Proc. 2010 Apr; 85(4):323-30. Epub 2010 Mar 01.
    View PubMed
62. Chang JY, Locke GR 3rd, McNally MA, Halder SL, Schleck CD, Zinsmeister AR, Talley NJ. Impact of functional gastrointestinal disorders on survival in the community. Am J Gastroenterol. 2010 Apr; 105(4):822-32. Epub 2010 Feb 16.
    View PubMed
63. Rubio-Tapia A, Talley NJ, Gurudu SR, Wu TT, Murray JA. Gluten-free diet and steroid treatment are effective therapy for most patients with collagenous sprue. Clin Gastroenterol Hepatol. 2010 Apr; 8(4):344-349.e3. Epub 2010 Jan 06.
    View PubMed
64. Gururatsakul M, Holloway RH, Adam B, Liebregts T, Talley NJ, Holtmann GJ. The ageing gut: diminished symptom response to a standardized nutrient stimulus. Neurogastroenterol Motil. 2010 Mar; 22(3):246-e77. Epub 2009 Oct 08.
    View PubMed
65. Haag S, Senf W, Tagay S, Heuft G, Gerken G, Talley NJ, Holtmann G. Is there any association between disturbed gastrointestinal visceromotor and sensory function and impaired quality of life in functional dyspepsia? Neurogastroenterol Motil. 2010 Mar; 22(3):262-e79. Epub 2009 Oct 08.
    View PubMed
66. Jung HK, Choung RS, Locke GR 3rd, Schleck CD, Zinsmeister AR, Talley NJ. Diarrhea-predominant irritable bowel syndrome is associated with diverticular disease: a population-based study. Am J Gastroenterol. 2010 Mar; 105(3):652-61. Epub 2009 Oct 27.
    View PubMed
67. Powell N, Walker MM, Talley NJ. Gastrointestinal eosinophils in health, disease and functional disorders. Nat Rev Gastroenterol Hepatol. 2010 Mar; 7(3):146-56. Epub 2010 Feb 02.
    View PubMed
68. Moayyedi P, Ford AC, Talley NJ, Cremonini F, Foxx-Orenstein AE, Brandt LJ, Quigley EM. The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review. Gut. 2010 Mar; 59(3):325-32. Epub 2008 Dec 17.
    View PubMed
69. Rey E, Choung RS, Schleck CD, Zinsmeister AR, Locke GR 3rd, Talley NJ. Onset and risk factors for fecal incontinence in a US community. Am J Gastroenterol. 2010 Feb; 105(2):412-9. Epub 2009 Oct 20.
    View PubMed
70. Kephart GM, Alexander JA, Arora AS, Romero Y, Smyrk TC, Talley NJ, Kita H. Marked deposition of eosinophil-derived neurotoxin in adult patients with eosinophilic esophagitis. Am J Gastroenterol. 2010 Feb; 105(2):298-307. Epub 2009 Nov 03.
    View PubMed
71. Ford AC, Guyatt GH, Talley NJ, Moayyedi P. Errors in the conduct of systematic reviews of pharmacological interventions for irritable bowel syndrome. Am J Gastroenterol. 2010 Feb; 105(2):280-8. Epub 2009 Nov 17.
    View PubMed
72. Saito YA, Rey E, Almazar-Elder AE, Harmsen WS, Zinsmeister AR, Locke GR, Talley NJ. A randomized, double-blind, placebo-controlled trial of St John's wort for treating irritable bowel syndrome. Am J Gastroenterol. 2010 Jan; 105(1):170-7. Epub 2009 Oct 06.
    View PubMed
73. Zhang L, Eslick GD, Xia HH, Wu C, Phung N, Talley NJ. Relationship between alcohol consumption and active Helicobacter pylori infection. Alcohol Alcohol. 2010 Jan-Feb; 45(1):89-94. Epub 2009 Oct 06.
    View PubMed
74. Cremonini F, Camilleri M, Clark MM, Beebe TJ, Locke GR, Zinsmeister AR, Herrick LM, Talley NJ. "Associations among binge eating behavior patterns and gastrointestinal symptoms: A population-based study": Corrigendum. Int J Obes. 2010 Jan; 34(1):214.
75. Jung HK, Choung RS, Talley NJ. Response to Dr Tursi. Am J Gastroenterol. 2010; 105(10):2293-4.
76. Talley NJ, Herrick L, Locke GR. Editorial: Antidepressants in functional dyspepsia. Expert rev. gastroenterol. Hepatol. 2010; 4(1):5-8.
77. Beebe TJ, Rey E, Ziegenfuss JY, Jenkins S, Lackore K, Talley NJ, Locke RG 3rd. Shortening a survey and using alternative forms of prenotification: impact on response rate and quality. BMC Med Res Methodol. 2010; 10:50. Epub 2010 Jun 08.
    View PubMed
78. Tack J, Talley NJ. Gastroduodenal disorders. Rev Gastroenterol Mex. 2010; 75(4):463-71.
79. Ford AC, Spiegel BM, Talley NJ, Moayyedi P. Small intestinal bacterial overgrowth in irritable bowel syndrome: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2009 Dec; 7(12):1279-86. Epub 2009 Aug 12.
    View PubMed
80. Cook IJ, Talley NJ, Benninga MA, Rao SS, Scott SM. Chronic constipation: overview and challenges. Neurogastroenterol Motil. 2009 Dec; 21 Suppl 2:1-8.
    View PubMed
81. Emmanuel AV, Tack J, Quigley EM, Talley NJ. Pharmacological management of constipation. Neurogastroenterol Motil. 2009 Dec; 21 Suppl 2:41-54.
    View PubMed
82. Spiegel B, Camilleri M, Bolus R, Andresen V, Chey WD, Fehnel S, Mangel A, Talley NJ, Whitehead WE. Psychometric evaluation of patient-reported outcomes in irritable bowel syndrome randomized controlled trials: a Rome Foundation report. Gastroenterology. 2009 Dec; 137(6):1944-53.e1-3. Epub 2009 Aug 23.
    View PubMed
83. Talley NJ. Response to mangel. Am J Gastroenterol. 2009 Dec; 104(12):3106.
    View PubMed
84. Talley NJ. So you aspire to be a Professor? World J Gastroenterol. 2009 Nov 28; 15(44):5626-5627.
    View PubMed
85. Eslick GD, Kalantar JS, Talley NJ. Rectal bleeding: epidemiology, associated risk factors, and health care seeking behaviour: a population-based study. Colorectal Dis. 2009 Nov; 11(9):921-6. Epub 2008 Oct 21.
    View PubMed
86. Kennedy AT, Weiser KT, Crowell MD, Talley NJ, Lacy BE. Functional dyspepsia: Validation and results of a novel survey instrument to evaluate patient knowledge and perceptions. J Clin Gastroenterol. 2009 Nov-Dec; 43(10):933-40.
    View PubMed
87. Rey E, Talley NJ. Irritable bowel syndrome: novel views on the epidemiology and potential risk factors. Dig Liver Dis. 2009 Nov; 41(11):772-80. Epub 2009 Aug 08.
    View PubMed
88. Jiang X, Locke GR, Zinsmeister AR, Schleck CD, Talley NJ. Health care seeking for abdominal bloating and visible distention. Aliment Pharmacol Ther. 2009 Oct; 30(7):775-83. Epub 2009 Jun 25.
    View PubMed
89. Chang JY, Locke GR 3rd, Schleck CD, Zinsmeister AR, Talley NJ. Risk factors for chronic diarrhoea in the community in the absence of irritable bowel syndrome. Neurogastroenterol Motil. 2009 Oct; 21(10):1060-e87. Epub 2009 May 21.
    View PubMed
90. Saito YA, Talley NJ. AJG series: molecular biology for clinicians. Am J Gastroenterol. 2009 Oct; 104(10):2583-7. Epub 2009 Jun 23.
    View PubMed
91. Prasad GA, Alexander JA, Schleck CD, Zinsmeister AR, Smyrk TC, Elias RM, Locke GR 3rd, Talley NJ. Epidemiology of eosinophilic esophagitis over three decades in Olmsted County, Minnesota. Clin Gastroenterol Hepatol. 2009 Oct; 7(10):1055-61. Epub 2009 Jul 01.
    View PubMed
92. Talley NJ, Choung RS. Whither dyspepsia? A historical perspective of functional dyspepsia, and concepts of pathogenesis and therapy in 2009. J Gastroenterol Hepatol. 2009 Oct; 24 Suppl 3:S20-8.
    View PubMed
93. Fock KM, Katelaris P, Sugano K, Ang TL, Hunt R, Talley NJ, Lam SK, Xiao SD, Tan HJ, Wu CY, Jung HC, Hoang BH, Kachintorn U, Goh KL, Chiba T, Rani AA, Second Asia-Pacific Conference. Second Asia-Pacific Consensus Guidelines for Helicobacter pylori infection. J Gastroenterol Hepatol. 2009 Oct; 24(10):1587-600.
    View PubMed
94. Gathaiya N, Locke GR 3rd, Camilleri M, Schleck CD, Zinsmeister AR, Talley NJ. Novel associations with dyspepsia: a community-based study of familial aggregation, sleep dysfunction and somatization. Neurogastroenterol Motil. 2009 Sep; 21(9):922-e69. Epub 2009 Jun 02.
    View PubMed
95. DeVault KR, Talley NJ. Insights into the future of gastric acid suppression. Nat Rev Gastroenterol Hepatol. 2009 Sep; 6(9):524-32.
    View PubMed
96. Talley NJ. Step-up and step-down treatment strategies did not differ for symptom relief at 6 months in new onset dyspepsia. Evid Based Med. 2009 Aug; 14(4):114.
    View PubMed
97. Choung RS, Locke GR 3rd, Zinsmeister AR, Schleck CD, Talley NJ. Psychosocial distress and somatic symptoms in community subjects with irritable bowel syndrome: a psychological component is the rule. Am J Gastroenterol. 2009 Jul; 104(7):1772-9. Epub 2009 Jun 02.
    View PubMed
98. Vakil N, Talley N, van Zanten SV, Flook N, Persson T, Bjorck E, Lind T, Bolling-Sternevald E, STARS I Study Group. Cost of detecting malignant lesions by endoscopy in 2741 primary care dyspeptic patients without alarm symptoms. Clin Gastroenterol Hepatol. 2009 Jul; 7(7):756-61. Epub 2009 Apr 10.
    View PubMed
99. Aro P, Talley NJ, Ronkainen J, Storskrubb T, Vieth M, Johansson SE, Bolling-Sternevald E, Agreus L. Anxiety is associated with uninvestigated and functional dyspepsia (Rome III criteria) in a Swedish population-based study. Gastroenterology. 2009 Jul; 137(1):94-100. Epub 2009 Mar 26.
    View PubMed
100. Talley NJ. Green light from the FDA for new drug development in irritable bowel syndrome and functional dyspepsia. Am J Gastroenterol. 2009 Jun; 104(6):1339-41.
     View PubMed
101. Choung RS, Locke GR 3rd, Zinsmeister AR, Schleck CD, Talley NJ. Opioid bowel dysfunction and narcotic bowel syndrome: a population-based study. Am J Gastroenterol. 2009 May; 104(5):1199-204. Epub 2009 Apr 14.
     View PubMed
102. Goodwin RD, Keyes KM, Stein MB, Talley NJ. Peptic ulcer and mental disorders among adults in the community: the role of nicotine and alcohol use disorders. Psychosom Med. 2009 May; 71(4):463-8.
     View PubMed
103. Walker MM, Talley NJ, Prabhakar M, Pennaneac'h CJ, Aro P, Ronkainen J, Storskrubb T, Harmsen WS, Zinsmeister AR, Agreus L. Duodenal mastocytosis, eosinophilia and intraepithelial lymphocytosis as possible disease markers in the irritable bowel syndrome and functional dyspepsia. Aliment Pharmacol Ther. 2009 Apr 1; 29(7):765-73. Epub 2009 Jan 17.
     View PubMed
104. Almansa C, Krishna M, Buchner AM, Ghabril MS, Talley N, DeVault KR, Wolfsen H, Raimondo M, Guarderas JC, Achem SR. Seasonal distribution in newly diagnosed cases of eosinophilic esophagitis in adults. Am J Gastroenterol. 2009 Apr; 104(4):828-33. Epub 2009 Feb 24.
     View PubMed
105. Jung HK, Choung RS, Locke GR 3rd, Schleck CD, Zinsmeister AR, Szarka LA, Mullan B, Talley NJ. The incidence, prevalence, and outcomes of patients with gastroparesis in Olmsted County, Minnesota, from 1996 to 2006. Gastroenterology. 2009 Apr; 136(4):1225-33. Epub 2008 Dec 24.
     View PubMed
106. Cremonini F, Camilleri M, Clark MM, Beebe TJ, Locke GR, Zinsmeister AR, Herrick LM, Talley NJ. Associations among binge eating behavior patterns and gastrointestinal symptoms: a population-based study. Int J Obes (Lond). 2009 Mar; 33(3):342-53. Epub 2009 Jan 13.
     View PubMed
107. Talley NJ, Seon Choung R. Functional (non-ulcer) dyspepsia and gastroparesis--differentiating these conditions and practical management approaches. Rev Gastroenterol Disord. 2009 Spring; 9(2):E48-53.
     View PubMed
108. Cremonini F, Camilleri M, Zinsmeister AR, Herrick LM, Beebe T, Talley NJ. Sleep disturbances are linked to both upper and lower gastrointestinal symptoms in the general population. Neurogastroenterol Motil. 2009 Feb; 21(2):128-35. Epub 2008 Sep 18.
     View PubMed
109. Eslick GD, Talley NJ. Gastroesophageal reflux disease (GERD): risk factors, and impact on quality of life-a population-based study. J Clin Gastroenterol. 2009 Feb; 43(2):111-7.
     View PubMed
110. Saito YA, Strege PR, Tester DJ, Locke GR 3rd, Talley NJ, Bernard CE, Rae JL, Makielski JC, Ackerman MJ, Farrugia G. Sodium channel mutation in irritable bowel syndrome: evidence for an ion channelopathy. Am J Physiol Gastrointest Liver Physiol. 2009 Feb; 296(2):G211-8. Epub 2008 Dec 04.
     View PubMed
111. Hart J, Hawkey CJ, Lanas A, Naesdal J, Talley NJ, Thomson ABR, Yeomans ND. Predictors of gastroduodenal erosions in patients taking low-dose aspirin. Aliment Pharmacol Ther. 2009 Jan 1; 31(1):143-9.
112. American College of Gastroenterology Task Force on Irritable Bowel Syndrome, Brandt LJ, Chey WD, Foxx-Orenstein AE, Schiller LR, Schoenfeld PS, Spiegel BM, Talley NJ, Quigley EM. An evidence-based position statement on the management of irritable bowel syndrome. Am J Gastroenterol. 2009 Jan; 104 Suppl 1:S1-35.
     View PubMed
113. Talley NJ, Lasch KL, Baum CL. A gap in our understanding: chronic constipation and its comorbid conditions. Clin Gastroenterol Hepatol. 2009 Jan; 7(1):9-19. Epub 2008 Oct 01.
     View PubMed
114. Agreus L, Storskrubb T, Aro P, Ronkainen J, Talley NJ, Sipponen P. Clinical use of proton-pump inhibitors but not H2-blockers or antacid/alginates raises the serum levels of amidated gastrin-17, pepsinogen I and pepsinogen II in a random adult population. Scand J Gastroenterol. 2009; 44(5):564-70.
     View PubMed
115. Talley NJ. Placebo acupuncture improved symptoms and quality of life in irritable bowel syndrome. Evid Based Med. 2008 Dec; 13(6):180.
     View PubMed
116. Rex DK, Talley NJ, Katz PO, Sandborn WJ, Hanauer SB. Report From the ACG: Highlights of the 72nd Annual Scientific Meeting of the American College of Gastroenterology, October 12-17, 2007, Philadelphia, PA. Rev Gastroenterol Disord. 2008 Winter; 8(1):42-57.
117. Ford AC, Talley NJ, Spiegel BMR, Foxx-Orenstein AE, Schiller L, Quigley EMM, Moayyedi P. Effect of fibre, antispasmodics and peppermint oil in the treatment of irritable bowel syndrome: system review and meta-analysis. BMJ. 2008 Nov 13; 337:A2313.
118. Bunch TJ, Packer DL, Jahangir A, Locke GR, Talley NJ, Gersh BJ, Roy RR, Hodge DO, Asirvatham SJ. Long-term risk of atrial fibrillation with symptomatic gastroesophageal reflux disease and esophagitis. Am J Cardiol. 2008 Nov 1; 102(9):1207-11. Epub 2008 Aug 27.
     View PubMed
119. Ford AC, Veldhuyzen van Zanten SJ, Rodgers CC, Talley NJ, Vakil NB, Moayyedi P. Diagnostic utility of alarm features for colorectal cancer: systematic review and meta-analysis. Gut. 2008 Nov; 57(11):1545-53. Epub 2008 Aug 01.
     View PubMed
120. Talley NJ. Subdividing functional dyspepsia: a paradigm shift? Gut. 2008 Nov; 57(11):1487-9.
     View PubMed
121. Chitkara DK, Talley NJ, Schleck C, Zinsmeister AR, Shah ND, Locke GR. Recollection of childhood abdominal pain in adults with functional gastrointestinal disorders. Scan J Gastroenterol. 2008 Nov:1-7.
122. Talley NJ. Genetics and functional bowel disease. J Pediatr Gastroenterol Nutr. 2008 Nov; 47(5):680-2.
     View PubMed
123. Ford AC, Talley NJ, Veldhuyzen van Zanten SJ, Vakil NB, Simel DL, Moayyedi P. Will the history and physical examination help establish that irritable bowel syndrome is causing this patient's lower gastrointestinal tract symptoms? JAMA. 2008 Oct 15; 300(15):1793-805.
     View PubMed
124. Pilichiewicz AN, Feltrin KL, Horowitz M, Holtmann G, Wishart JM, Jones KL, Talley NJ, Feinle-Bisset C. Functional dyspepsia is associated with a greater symptomatic response to fat but not carbohydrate, increased fasting and postprandial CCK, and diminished PYY. Am J Gastroenterol. 2008 Oct; 103(10):2613-23. Epub 2008 Sep 04.
     View PubMed
125. Crane SJ, Locke GR 3rd, Harmsen WS, Zinsmeister AR, Romero Y, Talley NJ. Survival trends in patients with gastric and esophageal adenocarcinomas: a population-based study. Mayo Clin Proc. 2008 Oct; 83(10):1087-94.
     View PubMed
126. Talley NJ. Reply to Dr. Kittisupamongkol. Am J Gastroenterol. 2008 Sep 04. [Epub ahead of print]
     View PubMed
127. Quan C, Talley NJ, Jones MP, Howell S, Horowitz M. Gastrointestinal symptoms and glycemic control in diabetes mellitus: a longitudinal population study. Eur J Gastroenterol Hepatol. 2008 Sep; 20(9):888-97.
     View PubMed
128. Eslick GD, Talley NJ. Natural history and predictors of outcome for non-cardiac chest pain: a prospective 4-year cohort study. Neurogastroenterol Motil. 2008 Sep; 20(9):989-97. Epub 2008 May 06.
     View PubMed
129. Talley NJ. RESPONSE TO THE LETTER. Am J Gastroenterol. 2008 Aug 27. [Epub ahead of print]
     View PubMed
130. Talley NJ. Is it time to screen and treat H pylori to prevent gastric cancer? Lancet. 2008 Aug 2; 372(9636):350-2.
     View PubMed
131. McNally MA, Locke GR, Zinsmeister AR, Schleck CD, Peterson J, Talley NJ. Biliary events and an increased risk of new onset irritable bowel syndrome: a population-based cohort study. Aliment Pharmacol Ther. 2008 Aug 1; 28(3):334-43.
     View PubMed
132. Rajan E, Gostout CJ, Lurken MS, Talley NJ, Locke GR, Szarka LA, Sumiyama K, Bakken TA, Stoltz GJ, Knipschield MA, Farrugia G. Endoscopic "no hole" full-thickness biopsy of the stomach to detect myenteric ganglia. Gastrointest Endosc. 2008 Aug; 68(2):301-7. Epub 2008 Feb 11.
     View PubMed
133. Bouras EP, Talley NJ, Camilleri M, Burton DD, Heckman MG, Crook JE, Richelson E. Effects of amitriptyline on gastric sensorimotor function and postprandial symptoms in healthy individuals: a randomized, double-blind, placebo-controlled trial. Am J Gastroenterol. 2008 Aug; 103(8):2043-50.
     View PubMed
134. Saito YA, Talley NJ. Genetics of irritable bowel syndrome. Am J Gastroenterol. 2008 Aug; 103(8):2100-4; quiz 2105. Epub 2008 Jul 05.
     View PubMed
135. Vakil N, Laine L, Talley NJ, Zakko SF, Tack J, Chey WD, Kralstein J, Earnest DL, Ligozio G, Cohard-Radice M. Tegaserod treatment for dysmotility-like functional dyspepsia: results of two randomized, controlled trials. Am J Gastroenterol. 2008 Aug; 103(8):1906-19. Epub 2008 Jul 04.
     View PubMed
136. Quan C, Talley NJ, Jones MP, Spies J, Horowitz M. Gain and loss of gastrointestinal symptoms in diabetes mellitus: associations with psychiatric disease, glycemic control, and autonomic neuropathy over 2 years of follow-up. Am J Gastroenterol. 2008 Aug; 103(8):2023-30.
     View PubMed
137. Jones MP, Talley NJ, Eslick GD, Dubois D, Tack J. Community subgroups in dyspepsia and their association with weight loss. Am J Gastroenterol. 2008 Aug; 103(8):2051-60.
     View PubMed
138. Saito YA, Zimmerman JM, Harmsen WS, De Andrade M, Locke GR 3rd, Petersen GM, Talley NJ. Irritable bowel syndrome aggregates strongly in families: a family-based case-control study. Neurogastroenterol Motil. 2008 Jul; 20(7):790-7.
     View PubMed
139. Shah ND, Chitkara DK, Locke GR, Meek PD, Talley NJ. Ambulatory care for constipation in the United States, 1993-2004. Am J Gastroenterol. 2008 Jul; 103(7):1746-53. Epub 2008 Jun 28.
     View PubMed
140. Talley NJ, Choung RS, Camilleri M, Dierkhising RA, Zinsmeister AR. Asimadoline, a kappa-opioid agonist, and satiation in functional dyspepsia. Aliment Pharmacol Ther. 2008 Jun 1; 27(11):1122-31. Epub 2008 Mar 07.
     View PubMed
141. Talley NJ. Chronic unexplained diarrhea: what to do when the initial workup is negative? Rev Gastroenterol Disord. 2008 Summer; 8(3):178-85.
     View PubMed
142. Walker MM, Talley NJ. Functional gastrointestinal disorders and the potential role of eosinophils. Gastroenterol Clin North Am. 2008 Jun; 37(2):383-95, vi.
     View PubMed
143. Choung RS, Talley NJ. Epidemiology and clinical presentation of stress-related peptic damage and chronic peptic ulcer. Curr Mol Med. 2008 Jun; 8(4):253-7.
     View PubMed
144. Prasad GA, Talley NJ. Eosinophilic esophagitis in adults. Gastroenterol Clin North Am. 2008 Jun; 37(2):349-68, v-vi.
     View PubMed
145. Talley NJ. Gut eosinophilia in food allergy and systemic and autoimmune diseases. Gastroenterol Clin North Am. 2008 Jun; 37(2):307-32, v.
     View PubMed
146. Talley NJ. Eosinophilic and autoimmune gastrointestinal disease: new insights and new entities. Preface. Gastroenterol Clin North Am. 2008 Jun; 37(2):xi-xii.
     View PubMed
147. Jiang X, Locke GR 3rd, Choung RS, Zinsmeister AR, Schleck CD, Talley NJ. Prevalence and risk factors for abdominal bloating and visible distention: a population-based study. Gut. 2008 Jun; 57(6):756-63.
     View PubMed
148. Talley NJ, Tack J, Ptak T, Gupta R, Giguere M. Itopride in functional dyspepsia: results of two phase III multicentre, randomised, double-blind, placebo-controlled trials. Gut. 2008 Jun; 57(6):740-6. Epub 2007 Oct 26.
     View PubMed
149. Talley NJ. Functional gastrointestinal disorders as a public health problem. Neurogastroenterol Motil. 2008 May; 20 Suppl 1:121-9.
     View PubMed
150. Stevens JE, Russo A, Maddox AF, Rayner CK, Phillips L, Talley NJ, Giguere M, Horowitz M, Jones KL. Effect of itopride on gastric emptying in longstanding diabetes mellitus. Neurogastroenterol Motil. 2008 May; 20(5):456-63. Epub 2008 Jan 07.
     View PubMed
151. Eslick GD, Talley NJ. Dysphagia: epidemiology, risk factors and impact on quality of life--a population-based study. Aliment Pharmacol Ther. 2008 May; 27(10):971-9. Epub 2008 Feb 28.
     View PubMed
152. Tuteja AK, Talley NJ, Joos SK, Tolman KG, Hickam DH. Abdominal bloating in employed adults: prevalence, risk factors, and association with other bowel disorders. Am J Gastroenterol. 2008 May; 103(5):1241-8. Epub 2008 Apr 16.
     View PubMed
153. McNally MA, Locke GR, Zinsmeister AR, Schleck CD, Peterson J, Talley NJ. Biliary events and an increased risk of new onset irritable bowel syndrome: A population-based cohort study. Aliment Pharmacol Ther. 2008 Apr 13. [Epub ahead of print]
     View PubMed
154. Haag S, Senf W, Hauser W, Tagay S, Grandt D, Heuft G, Gerken G, Talley NJ, Holtmann G. Impairment of health-related quality of life in functional dyspepsia and chronic liver disease: the influence of depression and anxiety. Aliment Pharmacol Ther. 2008 Apr 1; 27(7):561-71. Epub 2008 Jan 16.
     View PubMed
155. Topazian M, Camilleri M, De La Mora-Levy J, Enders FB, Foxx-Orenstein AE, Levy MJ, Nehra V, Talley NJ. Endoscopic ultrasound-guided gastric botulinum toxin injections in obese subjects: a pilot study. Obes Surg. 2008 Apr; 18(4):401-7. Epub 2008 Feb 20.
     View PubMed
156. Talley NJ. How to do and interpret a rectal examination in gastroenterology. Am J Gastroenterol. 2008 Apr; 103(4):820-2.
     View PubMed
157. Talley NJ. Commentary: Controversies in NICE guidance on irritable bowel syndrome. BMJ. 2008 Mar 8; 336(7643):558-9.
     View PubMed
158. Choung RS, Ferguson DD, Murray JA, Kammer PP, Dierkhising RA, Zinsmeister AR, Nurbhai S, Landau SB, Talley NJ. A novel partial 5HT3 agonist DDP733 after a standard refluxogenic meal reduces reflux events: a randomized, double-blind, placebo-controlled pharmacodynamic study. Aliment Pharmacol Ther. 2008 Mar 1; 27(5):404-11. Epub 2007 Dec 11.
     View PubMed
159. Talley NJ, Fock KM, Moayyedi P. Gastric Cancer Consensus conference recommends Helicobacter pylori screening and treatment in asymptomatic persons from high-risk populations to prevent gastric cancer. Am J Gastroenterol. 2008 Mar; 103(3):510-4.
     View PubMed
160. Choung RS, Cremonini F, Thapa P, Zinsmeister AR, Talley NJ. The effect of short-term, low-dose tricyclic and tetracyclic antidepressant treatment on satiation, postnutrient load gastrointestinal symptoms and gastric emptying: a double-blind, randomized, placebo-controlled trial. Neurogastroenterol Motil. 2008 Mar; 20(3):220-7. Epub 2007 Nov 20.
     View PubMed
161. Fock KM, Talley N, Moayyedi P, Hunt R, Azuma T, Sugano K, Xiao SD, Lam SK, Goh KL, Chiba T, Uemura N, Kim JG, Kim N, Ang TL, Mahachai V, Mitchell H, Rani AA, Liou JM, Vilaichone RK, Sollano J, Asia-Pacific Gastric Cancer Consensus Conference. Asia-Pacific consensus guidelines on gastric cancer prevention. J Gastroenterol Hepatol. 2008 Mar; 23(3):351-65.
     View PubMed
162. Moayyedi P, Burch N, Akhtar-Danesh N, Enaganti SK, Harrison R, Talley NJ, Jankowski J. Mortality rates in patients with Barrett's oesophagus. Aliment Pharmacol Ther. 2008 Feb 15; 27(4):316-20. Epub 2007 Dec 06.
     View PubMed
163. Hammer J, Talley NJ. Value of different diagnostic criteria for the irritable bowel syndrome among men and women. J Clin Gastroenterol. 2008 Feb; 42(2):160-6.
     View PubMed
164. Rajan E, Gostout CJ, Lurken MS, Talley NJ, Locke GR, Szarka LA, Levy MJ, Sumiyama K, de la Mora-Levy JG, Bakken TA, Stoltz GJ, Knipschield MA, Farrugia G. Evaluation of endoscopic approaches for deep gastric-muscle-wall biopsies: what works? Gastrointest Endosc. 2008 Feb; 67(2):297-303. Epub 2007 Oct 29.
     View PubMed
165. Talley NJ, Kellow JE, Boyce P, Tennant C, Huskic S, Jones M. Antidepressant therapy (imipramine and citalopram) for irritable bowel syndrome: a double-blind, randomized, placebo-controlled trial. Dig Dis Sci. 2008 Jan; 53(1):108-15. Epub 2007 May 15.
     View PubMed
166. Fock KM, Talley NJ, Fass R, Goh KL, Katelaris P, Hunt R, Hongo M, Ang TL, Holtmann G, Nandurkar S, Lin SR, Wong BC, Chan FK, Rani AA, Bak YT, Sollano J, Ho KY, Manatsathit S. Asia-Pacific consensus on the management of gastroesophageal reflux disease: update. J Gastroenterol Hepatol. 2008 Jan; 23(1):8-22.
     View PubMed
167. Talley NJ, Locke GR 3rd, McNally M, Schleck CD, Zinsmeister AR, Melton LJ 3rd. Impact of gastroesophageal reflux on survival in the community. Am J Gastroenterol. 2008 Jan; 103(1):12-9. Epub 2007 Sep 26.
     View PubMed
168. Barton PM, Moayyedi P, Talley NJ, Vakil NB, Delaney BC. A second-order simulation model of the cost-effectiveness of managing dyspepsia in the United States. Med Decis Making. 2008 Jan-Feb; 28(1):44-55. Epub 2007 Dec 05.
     View PubMed
169. Talley NJ. Lansoprazole was not effective in young dyspeptic patients without Helicobacter pylori. ACP J Club. 2008 Jan-Feb; 148(1):10.
     View PubMed
170. Tuteja AK, Talley NJ, Gelman SS, Alder SC, Thompson C, Tolman K, Hale DC. Development of functional diarrhea, constipation, irritable bowel syndrome, and dyspepsia during and after traveling outside the USA. Dig Dis Sci. 2008 Jan; 53(1):271-6. Epub 2007 Jun 05.
     View PubMed
171. Sandborn WJ, Vakil N, Talley NJ, Guda NM, Freeman ML, Hawes RH, Rex DK, Hanauer SB, Katz PO. Best of DDW 2008: Highlights from the 2008 Digestive Disease Week, May 17-22, 2008, San Diego, CA. Reviews in Gastroenterological Disorders. 2008; 8(2):123-54.
172. Bolling-Sternevald E, Aro P, Ronkainen J, Storskrubb T, Talley NJ, Junghard O, Agreus L. Do gastrointestinal symptoms fluctuate in the short-term perspective? The Kalixanda study. Dig Dis. 2008; 26(3):256-63. Epub 2008 May 07.
     View PubMed
173. Agreus L, Talley NJ, Sheen A, Johansson SE, Jones MP, Svardsudd K. Predictors and non-predictors of symptom relief in dyspepsia consultations in primary care. Dig Dis. 2008; 26(3):248-55. Epub 2008 May 07.
     View PubMed
174. Storskrubb T, Aro P, Ronkainen J, Sipponen P, Nyhlin H, Talley NJ, Engstrand L, Stolte M, Vieth M, Walker M, Agreus L. Serum biomarkers provide an accurate method for diagnosis of atrophic gastritis in a general population: The Kalixanda study. Scand J Gastroenterol. 2008; 43(12):1448-55.
     View PubMed
175. Talley NJ, Ruff K, Jiang X, Jung HK. The Rome III Classification of dyspepsia: will it help research? Dig Dis. 2008; 26(3):203-9. Epub 2008 May 06.
     View PubMed
176. Prasad GA, Talley NJ, Romero Y, Arora AS, Kryzer LA, Smyrk TC, Alexander JA. Prevalence and predictive factors of eosinophilic esophagitis in patients presenting with dysphagia: a prospective study. Am J Gastroenterol. 2007 Dec; 102(12):2627-32. Epub 2007 Aug 31.
     View PubMed
177. Choung RS, Locke GR 3rd, Schleck CD, Zinsmeister AR, Talley NJ. Cumulative incidence of chronic constipation: a population-based study 1988-2003. Aliment Pharmacol Ther. 2007 Dec; 26(11-12):1521-8. Epub 2007 Oct 05.
     View PubMed
178. Crane SJ, Talley NJ. Chronic gastrointestinal symptoms in the elderly. Clin Geriatr Med. 2007 Nov; 23(4):721-34, v.
     View PubMed
179. Chang JY, Locke GR, Schleck CD, Zinsmeister AR, Talley NJ. Risk factors for chronic constipation and a possible role of analgesics. Neurogastroenterol Motil. 2007 Nov; 19(11):905-11.
     View PubMed
180. Choung RS, Locke GR 3rd, Zinsmeister AR, Schleck CD, Talley NJ. Epidemiology of slow and fast colonic transit using a scale of stool form in a community. Aliment Pharmacol Ther. 2007 Oct 1; 26(7):1043-50.
     View PubMed
181. Levy RL, Finch EA, Crowell MD, Talley NJ, Jeffery RW. Behavioral intervention for the treatment of obesity: strategies and effectiveness data. Am J Gastroenterol. 2007 Oct; 102(10):2314-21. Epub 2007 Jun 11.
     View PubMed
182. Harrison R, Perry I, Haddadin W, McDonald S, Bryan R, Abrams K, Sampliner R, Talley NJ, Moayyedi P, Jankowski JA. Detection of Intestinal Metaplasia in Barrett's Esophagus. Am J Gastroenterol. 2007 Oct; 102(10):2353-4.
     View PubMed
183. Beebe TJ, Talley NJ, Camilleri M, Jenkins SM, Anderson KJ, Locke GR 3rd. The HIPAA authorization form and effects on survey response rates, nonresponse bias, and data quality: a randomized community study. Med Care. 2007 Oct; 45(10):959-65.
     View PubMed
184. Talley NJ, Walker MM, Aro P, Ronkainen J, Storskrubb T, Hindley LA, Harmsen WS, Zinsmeister AR, Agreus L. Non-ulcer dyspepsia and duodenal eosinophilia: an adult endoscopic population-based case-control study. Clin Gastroenterol Hepatol. 2007 Oct; 5(10):1175-83. Epub 2007 Aug 07.
     View PubMed
185. Talley NJ, Li Z. Helicobacter pylori: testing and treatment. Expert Rev Gastroenterol Hepatol. 2007 Oct; 1(1):71-9.
     View PubMed
186. Talley NJ. Introducing Expert Review of Gastroenterology and Hepatology. Expert Rev Gastroenterol Hepatol. 2007 Oct; 1(1):1-2.
     View PubMed
187. van Zanten SV, Flook N, Talley NJ, Vakil N, Lauritsen K, Bolling-Sternevald E, Persson T, Bjorck E, Svedberg LE, STARS II Study Group. One-week acid suppression trial in uninvestigated dyspepsia patients with epigastric pain or burning to predict response to 8 weeks' treatment with esomeprazole: a randomized, placebo-controlled study. Aliment Pharmacol Ther. 2007 Sep 1; 26(5):665-72.
     View PubMed
188. Talley NJ, Vakil N, Lauritsen K, van Zanten SV, Flook N, Bolling-Sternevald E, Persson T, Bjorck E, Lind T, STARS I Study Group. Randomized-controlled trial of esomeprazole in functional dyspepsia patients with epigastric pain or burning: does a 1-week trial of acid suppression predict symptom response? Aliment Pharmacol Ther. 2007 Sep 1; 26(5):673-82.
     View PubMed
189. Chitkara DK, Talley NJ, Locke GR 3rd, Weaver AL, Katusic SK, De Schepper H, Rucker MJ. Medical presentation of constipation from childhood to early adulthood: a population-based cohort study. Clin Gastroenterol Hepatol. 2007 Sep; 5(9):1059-64. Epub 2007 Jul 13.
     View PubMed
190. Talley NJ. Functional nausea and vomiting. Aust Fam Physician. 2007 Sep; 36(9):694-7.
     View PubMed
191. Halder SL, Locke GR 3rd, Schleck CD, Zinsmeister AR, Melton LJ 3rd, Talley NJ. Natural history of functional gastrointestinal disorders: a 12-year longitudinal population-based study. Gastroenterology. 2007 Sep; 133(3):799-807. Epub 2007 Jun 20.
     View PubMed
192. Choung RS, Locke GR, Schleck CD, Zinsmeister AR, Talley NJ. Do distinct dyspepsia subgroups exist in the community? A population-based study. Am J Gastroenterol. 2007 Sep; 102(9):1983-9. Epub 2007 Jun 20.
     View PubMed
193. Jung HK, Halder S, McNally M, Locke GR 3rd, Schleck CD, Zinsmeister AR, Talley NJ. Overlap of gastro-oesophageal reflux disease and irritable bowel syndrome: prevalence and risk factors in the general population. Aliment Pharmacol Ther. 2007 Aug 1; 26(3):453-61.
     View PubMed
194. Crane SJ, Locke GR 3rd, Harmsen WS, Diehl NN, Zinsmeister AR, Melton LJ 3rd, Romero Y, Talley NJ. Subsite-specific risk factors for esophageal and gastric adenocarcinoma. Am J Gastroenterol. 2007 Aug; 102(8):1596-602. Epub 2007 Apr 24.
     View PubMed
195. Halder SL, Talley NJ. Functional Dyspepsia: A New Rome III Paradigm. Curr Treat Options Gastroenterol. 2007 Aug; 10(4):259-72.
     View PubMed
196. Lembo A, Zaman M, Jones M, Talley NJ. Influence of genetics on irritable bowel syndrome, gastro-oesophageal reflux and dyspepsia: a twin study. Aliment Pharmacol Ther. 2007 Jun 1; 25(11):1343-50.
     View PubMed
197. Harrison R, Perry I, Haddadin W, McDonald S, Bryan R, Abrams K, Sampliner R, Talley NJ, Moayyedi P, Jankowski JA. Detection of intestinal metaplasia in Barrett's esophagus: an observational comparator study suggests the need for a minimum of eight biopsies. Am J Gastroenterol. 2007 Jun; 102(6):1154-61. Epub 2007 Apr 13.
     View PubMed
198. Saito YA, Locke GR 3rd, Zimmerman JM, Holtmann G, Slusser JP, de Andrade M, Petersen GM, Talley NJ. A genetic association study of 5-HTT LPR and GNbeta3 C825T polymorphisms with irritable bowel syndrome. Neurogastroenterol Motil. 2007 Jun; 19(6):465-70.
     View PubMed
199. Cash BD, Chang E, Talley NJ, Wald A. Fresh perspectives in chronic constipation and other functional bowel disorders. Rev Gastroenterol Disord. 2007 Summer; 7(3):116-33.
     View PubMed
200. Ronkainen J, Talley NJ, Aro P, Storskrubb T, Johansson SE, Lind T, Bolling-Sternevald E, Vieth M, Stolte M, Walker MM, Agreus L. Prevalence of oesophageal eosinophils and eosinophilic oesophagitis in adults: the population-based Kalixanda study. Gut. 2007 May; 56(5):615-20.
     View PubMed
201. Camilleri M, Mangel AW, Fehnel SE, Drossman DA, Mayer EA, Talley NJ. Primary endpoints for irritable bowel syndrome trials: a review of performance of endpoints. Clin Gastroenterol Hepatol. 2007 May; 5(5):534-40. Epub 2007 Apr 11.
     View PubMed
202. Haag S, Senf W, Tagay S, Langkafel M, Braun-Lang U, Pietsch A, Heuft G, Talley NJ, Holtmann G. Is there a benefit from intensified medical and psychological interventions in patients with functional dyspepsia not responding to conventional therapy? Aliment Pharmacol Ther. 2007 Apr 15; 25(8):973-86.
     View PubMed
203. Hawkey CJ, Jones RH, Yeomans ND, Scheiman JM, Talley NJ, Goldstein JL, Ahlbom H, Naesdal J. Efficacy of esomeprazole for resolution of symptoms of heartburn and acid regurgitation in continuous users of non-steroidal anti-inflammatory drugs. Aliment Pharmacol Ther. 2007 Apr 1; 25(7):813-21.
     View PubMed
204. Liebregts T, Adam B, Bredack C, Roth A, Heinzel S, Lester S, Downie-Doyle S, Smith E, Drew P, Talley NJ, Holtmann G. Immune activation in patients with irritable bowel syndrome. Gastroenterology. 2007 Mar; 132(3):913-20.
     View PubMed
205. Choung RS, Talley NJ, Peterson J, Camilleri M, Burton D, Harmsen WS, Zinsmeister AR. A double-blind, randomized, placebo-controlled trial of itopride (100 and 200 mg three times daily) on gastric motor and sensory function in healthy volunteers. Neurogastroenterol Motil. 2007 Mar; 19(3):180-7.
     View PubMed
206. Talley NJ. Functional Gastrointestinal Disorders in 2007 and Rome III: something new, something borrowed, something objective. Rev Gastroenterol Disord. 2007 Spring; 7(2):97-105.
     View PubMed
207. McNally MA, Talley NJ. Current treatments in functional dyspepsia. Curr Treat Options Gastroenterol. 2007 Mar; 10(2):157-68.
     View PubMed
208. Crane SJ, Locke GR 3rd, Harmsen WS, Diehl NN, Zinsmeister AR, Melton LJ 3rd, Romero Y, Talley NJ. The changing incidence of oesophageal and gastric adenocarcinoma by anatomic sub-site. Aliment Pharmacol Ther. 2007 Feb 15; 25(4):447-53.
     View PubMed
209. Chitkara DK, Talley NJ, Weaver AL, Katusic SK, De Schepper H, Rucker MJ, Locke GR 3rd. Incidence of presentation of common functional gastrointestinal disorders in children from birth to 5 years: a cohort study. Clin Gastroenterol Hepatol. 2007 Feb; 5(2):186-91.
     View PubMed
210. Liebregts T, Adam B, Bertel A, Lackner C, Neumann J, Talley NJ, Gerken G, Holtmann G. Psychological stress and the severity of post-inflammatory visceral hyperalgesia. Eur J Pain. 2007 Feb; 11(2):216-22.
     View PubMed
211. Richter JE, Talley NJ. American Journal of Gastroenterology 2006: The Best Clinical GI Journal in the World. Am J Gastroenterol. 2007 Feb; 102(2):229-31.
     View PubMed
212. Talley NJ. How to manage the difficult-to-treat dyspeptic patient. Nat Clin Pract Gastroenterol Hepatol. 2007 Jan; 4(1):35-42.
     View PubMed
213. Bueno L, De Ponti F, Fried M, Kullak-Ublick GA, Kwiatek MA, Pohl D, Quigley EMM, Tack J, Talley NJ. Serotonergic and non-serotonergic targets in the pharmacotherapy of visceral hypersensitivity. Neurogastroenterol Motil. 2007 Jan; 19(Suppl 1):89-119.
     View PubMed
214. Talley NJ. Irritable bowel syndrome: rational therapy. Consultant. 2007 Jan; 47(1):81-3, 87-8, 89-90.
215. Hawkey CJ, Talley NJ, Scheiman JM, Jones RH, Langstrom G, Naesdal J, Yeomans ND, NASA/SPACE author group. Maintenance treatment with esomeprazole following initial relief of non-steroidal anti-inflammatory drug-associated upper gastrointestinal symptoms: the NASA2 and SPACE2 studies. Arthritis Res Ther. 2007; 9(1):R17.
     View PubMed
216. Grudell AB, Alexander JA, Enders FB, Pacifico R, Fredericksen M, Wise JL, Locke GR 3rd, Arora A, Zais T, Talley NJ, Romero Y. Validation of the Mayo Dysphagia Questionnaire. Dis Esophagus. 2007; 20(3):202-5.
     View PubMed
217. Choung RS, Talley NJ. Food allergy and intolerance in IBS. J Gastroenterol Hepatol. 2007; 2:756-60.
218. Hanauer SB, Sandborn WJ, Vakil N, Katz PO, Talley NJ, Rex DK, Hawes RH, Guda NM, Freeman ML. Best of DDW 2007. Rev Gastroenterol Disor. 2007; 7(3):134-66.
219. Kalantar JS, Talley NJ. Towards a diagnosis of functional dyspepsia. Med Today. 2007; 8(12):45-50.
220. Talley NJ. The role of endoscopy in dyspepsia. ASGE Clinical Update. 2007; 15(1):1-4.
221. Crowell MD, Decker GA, Levy R, Jeffrey R, Talley NJ. Gut-brain neuropeptides in the regulation of ingestive behaviors and obesity. Am J Gastroenterol. 2006 Dec; 101(12):2848-56; quiz 2914. Epub 2006 Oct 06.
     View PubMed
222. Talley NJ. Irritable bowel syndrome. Intern Med J. 2006 Nov; 36(11):724-8.
     View PubMed
223. Cremonini F, Locke GR 3rd, Schleck CD, Zinsmeister AR, Talley NJ. Relationship between upper gastrointestinal symptoms and changes in body weight in a population-based cohort. Neurogastroenterol Motil. 2006 Nov; 18(11):987-94.
     View PubMed
224. Halder SL, Locke GR 3rd, Schleck CD, Zinsmeister AR, Talley NJ. Influence of alcohol consumption on IBS and dyspepsia. Neurogastroenterol Motil. 2006 Nov; 18(11):1001-8.
     View PubMed
225. Chitkara DK, Van Tilburg M, Whitehead WE, Talley NJ. Teaching diaphragmatic breathing for rumination syndrome. Am J Gastroenterol. 2006 Nov; 101(11):2449-52.
     View PubMed
226. Koloski NA, Boyce PM, Talley NJ. Somatization an independent psychosocial risk factor for irritable bowel syndrome but not dyspepsia: a population-based study. Eur J Gastroenterol Hepatol. 2006 Oct; 18(10):1101-9.
     View PubMed
227. Talley NJ, Camilleri M, Burton D, Thomforde G, Koch K, Rucker MJ, Peterson J, Zinsmeister AR, Earnest DL. Double-blind, randomized, placebo-controlled study to evaluate the effects of tegaserod on gastric motor, sensory and myoelectric function in healthy volunteers. Aliment Pharmacol Ther. 2006 Sep 1; 24(5):859-67.
     View PubMed
228. Storskrubb T, Aro P, Ronkainen J, Wreiber K, Nyhlin H, Bolling-Sternevald E, Talley NJ, Engstrand L, Agreus L. Antimicrobial susceptibility of Helicobacter pylori strains in a random adult Swedish population. Helicobacter. 2006 Aug; 11(4):224-30.
     View PubMed
229. Vakil N, Moayyedi P, Fennerty MB, Talley NJ. Limited value of alarm features in the diagnosis of upper gastrointestinal malignancy: systematic review and meta-analysis. Gastroenterology. 2006 Aug; 131(2):390-401; quiz 659-60.
     View PubMed
230. Talley NJ, Armstrong D, Junghard O, Wiklund I. Predictors of treatment response in patients with non-erosive reflux disease. Aliment Pharmacol Ther. 2006 Jul 15; 24(2):371-6.
     View PubMed
231. Hammer J, Talley NJ. Disturbed bowel habits in patients with non-ulcer dyspepsia. Aliment Pharmacol Ther. 2006 Jul 15; 24(2):405-10.
     View PubMed
232. Vakil N, Talley NJ, Stolte M, Sundin M, Junghard O, Bolling-Sternevald E. Patterns of gastritis and the effect of eradicating Helicobacter pylori on gastro-oesophageal reflux disease in Western patients with non-ulcer dyspepsia. Aliment Pharmacol Ther. 2006 Jul 1; 24(1):55-63.
     View PubMed
233. Talley NJ, Locke GR 3rd, Lahr BD, Zinsmeister AR, Tougas G, Ligozio G, Rojavin MA, Tack J. Functional dyspepsia, delayed gastric emptying, and impaired quality of life. Gut. 2006 Jul; 55(7):933-9. Epub 2005 Dec 01.
     View PubMed
234. Talley NJ. Overlapping abdominal symptoms: why do GERD and IBS often coexist? Drugs Today (Barc) 2006 Jul; 42 Suppl B:3-8.
     View PubMed
235. Chitkara DK, Bredenoord AJ, Talley NJ, Whitehead WE. Aerophagia and rumination: recognition and therapy. Curr Treat Options Gastroenterol. 2006 Jul; 9(4):305-13.
     View PubMed
236. Moayyedi P, Talley NJ. Gastro-oesophageal reflux disease. Lancet. 2006 Jun 24; 367(9528):2086-100.
     View PubMed
237. Ronkainen J, Aro P, Storskrubb T, Lind T, Bolling-Sternevald E, Junghard O, Talley NJ, Agreus L. Gastro-oesophageal reflux symptoms and health-related quality of life in the adult general population--the Kalixanda study. Aliment Pharmacol Ther. 2006 Jun 15; 23(12):1725-33.
     View PubMed
238. Choung RS, Locke GR 3rd, Zinsmeister AR, Melton LJ 3rd, Talley NJ. Alternating bowel pattern: what do people mean? Aliment Pharmacol Ther. 2006 Jun 15; 23(12):1749-55.
     View PubMed
239. Aro P, Storskrubb T, Ronkainen J, Bolling-Sternevald E, Engstrand L, Vieth M, Stolte M, Talley NJ, Agreus L. Peptic ulcer disease in a general adult population: the Kalixanda study: a random population-based study. Am J Epidemiol. 2006 Jun 1; 163(11):1025-34. Epub 2006 Mar 22.
     View PubMed
240. Andresen V, Camilleri M, Kim HJ, Stephens DA, Carlson PJ, Talley NJ, Saito YA, Urrutia R, Zinsmeister AR. Is there an association between GNbeta3-C825T genotype and lower functional gastrointestinal disorders? Gastroenterology. 2006 Jun; 130(7):1985-94.
     View PubMed
241. Howell SC, Quine S, Talley NJ. Low social class is linked to upper gastrointestinal symptoms in an Australian sample of urban adults. Scand J Gastroenterol. 2006 Jun; 41(6):657-66.
     View PubMed
242. Saito YA, Talley NJ, de Andrade M, Petersen GM. Case-control genetic association studies in gastrointestinal disease: review and recommendations. Am J Gastroenterol. 2006 Jun; 101(6):1379-89.
     View PubMed
243. Hanauer SB, Sandborn WJ, Vakil N, Katz PO, Talley NJ, Rex DK, Hawes RH, Guda NM, Freeman ML, Keeffe EB, Balart LA. Best of DDW 2006. Rev Gastroenterol Disord. 2006 Summer; 6(3):153-89.
     View PubMed
244. Talley NJ, Locke GR, Lahr BD, Zinsmeister AR, Cohard-Radice M, D'Elia TV, Tack J, Earnest DL. Predictors of the placebo response in functional dyspepsia. Aliment Pharmacol Ther. 2006 Apr 1; 23(7):923-36.
     View PubMed
245. Talley NJ. How effective is fluoxetine for the treatment of pain and constipation-predominant irritable bowel syndrome? Nat Clin Pract Gastroenterol Hepatol. 2006 Apr; 3(4):196-7.
     View PubMed
246. Tack J, Talley NJ, Camilleri M, Holtmann G, Hu P, Malagelada JR, Stanghellini V. Functional gastroduodenal disorders. Gastroenterology. 2006 Apr; 130(5):1466-79.
     View PubMed
247. Tally NJ. Chronic constipation and irritable bowel syndrome: epidemiology, presentation, and diagnosis... includes discussion. Advanced Studies in Medicine. 2006 Apr; 6(4A):S225-31, S251-3.
248. Design of Treatment Trials Committee, Irvine EJ, Whitehead WE, Chey WD, Matsueda K, Shaw M, Talley NJ, Veldhuyzen van Zanten SJ. Design of treatment trials for functional gastrointestinal disorders. Gastroenterology. 2006 Apr; 130(5):1538-51.
     View PubMed
249. Scheiman JM, Yeomans ND, Talley NJ, Vakil N, Chan FK, Tulassay Z, Rainoldi JL, Szczepanski L, Ung KA, Kleczkowski D, Ahlbom H, Naesdal J, Hawkey C. Prevention of ulcers by esomeprazole in at-risk patients using non-selective NSAIDs and COX-2 inhibitors. Am J Gastroenterol. 2006 Apr; 101(4):701-10. Epub 2006 Feb 22.
     View PubMed
250. Malfertheiner P, Fass R, Quigley EM, Modlin IM, Malagelada JR, Moss SF, Holtmann G, Goh KL, Katelaris P, Stanghellini V, Talley NJ, Tytgat GN, Wright NA. Review article: from gastrin to gastro-oesophageal reflux disease--a century of acid suppression. Aliment Pharmacol Ther. 2006 Mar 15; 23(6):683-90.
     View PubMed
251. Talley NJ. A unifying hypothesis for the functional gastrointestinal disorders: really multiple diseases or one irritable gut? Rev Gastroenterol Disord. 2006 Spring; 6(2):72-8.
     View PubMed
252. Holtmann G, Talley NJ, Liebregts T, Adam B, Parow C. A placebo-controlled trial of itopride in functional dyspepsia. N Engl J Med. 2006 Feb 23; 354(8):832-40.
     View PubMed
253. Talley NJ, Richter J. Nobel Prize in Medicine awarded to a Gastroenterologist in 2005. Am J Gastroenterol. 2006 Feb; 101(2):211.
     View PubMed
254. Fajardo NR, Wise JL, Locke GR 3rd, Murray JA, Talley NJ. Esophageal perforation after placement of wireless Bravo pH probe. Gastrointest Endosc. 2006 Jan; 63(1):184-5.
     View PubMed
255. Boyce PM, Talley NJ, Burke C, Koloski NA. Epidemiology of the functional gastrointestinal disorders diagnosed according to Rome II criteria: an Australian population-based study. Intern Med J. 2006 Jan; 36(1):28-36.
     View PubMed
256. Moayyedi P, Talley NJ, Fennerty MB, Vakil N. Can the clinical history distinguish between organic and functional dyspepsia? JAMA. 2006; 295:1566-76.
257. Talley NA, Talley NJ. Hepatitis C: diagnosis and management issues. Australian Defense Force Health. 2006; 7:22-8.
258. Stolte M, Muller H, Talley NJ, O'morain C, Bolling-Sternevald E, Sundin M, Eriksson S, Blum A. In patients with Helicobacter pylori gastritis and functional dyspepsia, a biopsy from the incisura angularis provides useful diagnostic information. Pathol Res Pract. 2006; 202(6):405-13. Epub 2006 May 05.
     View PubMed
259. Hancox RJ, Poulton R, Taylor DR, Greene JM, McLachlan CR, Cowan JO, Flannery EM, Herbison GP, Sears MR, Talley NJ. Associations between respiratory symptoms, lung function and gastro-oesophageal reflux symptoms in a population-based birth cohort. Respir Res. 2006; 7:142. Epub 2006 Dec 05.
     View PubMed
260. Rex DK, Talley NJ, Katz PO, Hanauer SB, Sandborn WJ. Report from the ACG: Highlights of the 71st Annual Scientific Meeting of the American College of Gastroenterology, October 20-25, Las Vegas, NV. Reviews in Gastroenterological Disorders. 2006; 6(4):227-42.
261. Fajardo NR, Cremonini F, Talley NJ. Management of constipation in patients with cancer. Am J Cancer. 2006; 5(5):319-30.
262. Choung RS, Talley NJ. Food allergy and intolerance in IBS. Gastroenterol. Hepatol. 2006; 2(10):756-60.
263. Rex DK, Hanauer SB, Sandborn WJ, Katz PO, Talley NJ. Report from the ACG. Highlights of the 70th Annual Scientific Meeting of the American College of Gastroenterology October 28-November 2, 2005, Honolulu, HI. Reviews in Gastroenterological Disorders. 2006; 6(1):35-47.
264. Talley N. Stop your intestines from rebelling. Bottom Line/Health. 2005 Dec; 19(12):5-6.
265. Saito YA, Locke GR, Weaver AL, Zinsmeister AR, Talley NJ. Diet and functional gastrointestinal disorders: A population-based case-control study. Am J Gastroenterol. 2005 Dec; 100(12):2743-8.
     View PubMed
266. Ronkainen J, Aro P, Storskrubb T, Johansson SE, Lind T, Bolling-Sternevald E, Vieth M, Stolte M, Talley NJ, Agreus L. Prevalence of Barrett's esophagus in the general population: An endoscopic study. Gastroenterology. 2005 Dec; 129(6):1825-31.
     View PubMed
267. Talley NJ. Differentiating functional constipation from constipation-predominant irritable bowel syndrome: management implications. Rev Gastroenterol Disord. 2005 Winter; 5(1):1-9.
     View PubMed
268. Yeomans ND, Lanas AI, Talley NJ, Thomson ABR, Daneshjoo R, Eriksson B, Appelman-Eszczuk S, Langstrom G, Naesdal J, Serrano P, Singh M, Skelly MM, Hawkey CJ. Prevalence and incidence of gastroduodenal ulcers during treatment with vascular protective doses of aspirin. Aliment Pharmacol Ther. 2005 Nov 1; 22(9):795-801.
     View PubMed
269. Chitkara DK, Bredenoord AJ, Rucker MJ, Talley NJ. Aerophagia in adults: a comparison with functional dyspepsia. Aliment Pharmacol Ther2005 Nov 1; 22(9):855-8.
     View PubMed
270. Wise JL, Locke GR, Zinsmeister AR, Talley NJ. Risk factors for non-cardiac chest pain in the community. Aliment Pharmacol Ther 2005 Nov; 22(10):1023-31.
     View PubMed
271. Saito YA, Petersen GM, Locke GR 3rd, Talley NJ. The genetics of irritable bowel syndrome. Clin Gastroenterol Hepatol. 2005 Nov; 3(11):1057-65.
     View PubMed
272. Talley NJ, Vakil NB, Moayyedi P. American gastroenterological association technical review on the evaluation of dyspepsia. Gastroenterology. 2005 Nov; 129(5):1756-80.
     View PubMed
273. Talley NJ. Review: prompt endoscopy is not a cost-effective strategy for initial management of dyspepsia. ACP J Club. 2005 Nov-Dec; 143(3):76.
     View PubMed
274. Aro P, Ronkainen J, Talley NJ, Storskrubb T, Bolling-Sternevald E, Agreus L. Body mass index and chronic unexplained gastrointestinal symptoms: an adult endoscopic population based study. Gut. 2005 Oct; 54(10):1377-83.
     View PubMed
275. Talley NJ, Vakil N. Guidelines for the management of dyspepsia. Am J Gastroenterol. 2005 Oct; 100(10):2324-37.
     View PubMed
276. Eslick GD, Coulshed DS, Talley NJ. Diagnosis and treatment of noncardiac chest pain. Nat Clin Pract Gastroenterol Hepatol. 2005 Oct; 2(10):463-72.
     View PubMed
277. Howell S, Poulton R, Talley NJ. The natural history of childhood abdominal pain and its association with adult irritable bowel syndrome: Birth-cohort study. Am J Gastroenterol. 2005 Sep; 100(9):2071-8.
     View PubMed
278. Ahlawat SK, Richard Locke G, Weaver AL, Farmer SA, Yawn BP, Talley NJ. Dyspepsia consulters and patterns of management: a population-based study. Aliment Pharmacol Ther. 2005 Aug 1; 22(3):251-9.
     View PubMed
279. Burton DD, Kim HJ, Camilleri M, Stephens DA, Mullan BP, O'Connor MK, Talley NJ. Relationship of gastric emptying and volume changes after a solid meal in humans. Am J Physiol Gastrointest Liver Physiol. 2005 Aug; 289(2):G261-6.
280. Chitkara DK, Bredenood AJ, Wang M, Rucker MJ, Talley NJ. Aerophagia in children: characterization of a functional gastrointestinal disorder. Neurogastroenterol Motil. 2005 Aug; 17(4):518-22.
     View PubMed
281. Chitkara DK, Rawat DJ, Talley NJ. The epidemiology of childhood recurrent abdominal pain in western countries: A systematic review. Am J Gastroenterol. 2005 Aug; 100(8):1868-75.
     View PubMed
282. Fajardo NR, Cremonini F, Talley NJ. Frontiers in functional dyspepsia. Curr Gastroenterol Rep. 2005 Aug; 7(4):289-96.
     View PubMed
283. Nandurkar S, Locke GR, Murray JA, Melton LJ, Zinsmeister AR, Dierkhising R, Talley NJ. Rates of endoscopy and endoscopic findings among people with frequent symptoms of gastroesophageal reflux in the community. Am J Gastroenterol. 2005 Jul; 100(7):1459-65.
     View PubMed
284. Fawcett JP, Barbezat GO, Poulton R, Milne BJ, Xia HH, Talley NJ. Helicobacter pylori serology in a birth cohort of New Zealanders from age 11 to 26. World J Gastroenterol. 2005 Jun 7; 11(21):3273-6.
     View PubMed
285. Camilleri M, Dubois D, Coulie B, Jones M, Kahrilas PJ, Rentz AM, Sonnenberg A, Stanghellini V, Stewart WF, Tack J, Talley NJ, Whitehead W, Revicki DA. Prevalence and socioeconomic impact of upper gastrointestinal disorders in the United States: results of the US Upper Gastrointestinal Study. Clin Gastroenterol Hepatol. 2005 Jun; 3(6):543-52.
     View PubMed
286. Cremonini F, Wise J, Moayyedi P, Talley NJ. Diagnostic and therapeutic use of proton pump inhibitors in non-cardiac chest pain: A metaanalysis. Am J Gastroenterol. 2005 Jun; 100(6):1226-32.
     View PubMed
287. Cremonini F, Talley NJ. Irritable bowel syndrome: epidemiology, natural history, health care seeking and emerging risk factors. Gastroenterol Clin North Am. 2005 Jun; 34(2):189-204.
     View PubMed
288. Hawkey C, Talley NJ, Yeomans ND, Jones R, Sung JJY, Langstrom G, Naesdal J, Scheiman JM. Improvements with esomeprazole in patients with upper gastrointestinal symptoms taking non-steroidal antiinflammatory drugs, including selective COX-2 inhibitors. Am J Gastroenterol. 2005 May; 100(5):1028-36.
     View PubMed
289. Cremonini F, Talley NJ. Treatments targeting putative mechanisms in irritable bowel syndrome. Nat Clin Pract Gastroenterol Hepatol. 2005 Feb; 2(2):82-8.
     View PubMed
290. Locke GR, Zinsmeister AR, Fett SL, Melton LJ, Talley NJ. Overlap of gastrointestional symptom complexes in a US community. Neurogastroenterology & Motility. 2005 Feb; 17(1):29-34.
     View PubMed
291. Kamm MA, Muller-Lissner S, Talley NJ, Tack J, Boeckxstaens G, Minushkin ON, Kalinin A, Dzieniszewski J, Haeck P, Fordham F, Hugot-Cournez S, Nault B. Tegaserod for the treatment of chronic constipation: A randomized, double-blind, placebo-controlled multinational study. Am J Gastroenterol. 2005 Feb; 100(2):362-72.
     View PubMed
292. Talley NJ, Wiklund I. Patient reported outcomes in gastroesophageal reflux disease: An overview of available measures. Qual Life Res. 2005 Feb; 14(1):21-33.
     View PubMed
293. Ronkainen J, Aro P, Storskrubb T, Johansson SE, Lind T, Bolling-Sternevald E, Graffner H, Vieth M, Stolte M, Engstrand L, Talley NJ, Agreus L. High prevalence of gastroesophageal reflux symptoms and esophagitis with or without symptoms in the general adult Swedish population: A Kalixanda study report. Scand J Gastroenterol. 2005 Feb; 40(3):275-85.
     View PubMed
294. Storskrubb T, Aro P, Ronkainen J, Vieth M, Stolte M, Wreiber K, Engstrand L, Nyhlin H, Bolling-Sternevald E, Talley NJ, Agreus L. A negative Helicobacter pylori serology test is more reliable for exclusion of premalignant gastric conditions than a negative test for current H-pylori infection: A report on histology and H-pylori detection in the general adult population. Scand J Gastroenterol. 2005 Feb; 40(3):302-11.
     View PubMed
295. Cuddihy MT, Locke GR, Wahner-Roedler D, Dierkhising R, Zinsmeister AR, Long KH, Talley NJ. Dyspepsia management in primary care: a management trial. Int J Clin Pract. 2005 Feb; 59(2):194-201.
     View PubMed
296. Koloski NA, Boyce PM, Talley NJ. Is health care seeking for irritable bowel syndrome and functional dyspepsia a socially learned response to illness? Dig Dis Sci. 2005 Jan; 50(1):153-62.
     View PubMed
297. Tuteja AK, Talley NJ, Joos SK, Woehl JV, Hickam DH. Is constipation associated with decreased physical activity in normally active subjects? Am J Gastroenterol. 2005 Jan; 100(1):124-9.
     View PubMed
298. Talley NJ. Environmental versus genetic risk factors for irritable bowel syndrome: clinical and therapeutic implications. Rev Gastroenterol Disord. 2005; 5(2):82-8.
     View PubMed
299. Brandt LJ, Schoenfeld P, Prather CM, Quigley EMM, Schiller LR, Talley NJ. Evidence-based position statement on the management of chronic constipation in North America. Am J Gastroenterol. 2005; 100(1 Suppl S):1-4.
300. Brandt LJ, Prather CM, Quigley EMM, Schiller LR, Schoenfeld P, Talley NJ. Systematic review on the management of chronic constipation in North America. Am J Gastroenterol. 2005; 100(1 Suppl S):S5-S22.
     View PubMed
301. Koloski NA, Talley NJ, Boyce PM. A history of abuse in community subjects with irritable bowel syndrome and functional dyspepsia: The role of other psychosocial variables. Digestion. 2005; 72(2-3):86-96.
     View PubMed
302. Talley NJ, Camilleri M, Chitkara DK, Bouras E, Locke GR, Burton D, Rucker MJ, Thapa P, Zinsmeister AR. Effects of desipramine and escitalopram on postprandial symptoms induced by the nutrient drink test in healthy volunteers: A randomized, double-blind, placebo-controlled study. Digestion. 2005; 72(2-3):97-103.
     View PubMed
303. Halder SLS, Talley NJ. Treatment of functional dyspepsia. Curr Treat Options Gastroenterol. 2005; 8(4):325-36.
     View PubMed
304. Talley NJ. Epidemiology, severity, and impact of irritable bowel syndrome. Pract Gastroenterol. 2005; 29(4 Suppl):4-12.
305. de la Loge C, Trudeau E, Marquis P, Kahrilas P, Stanghellini V, Talley NJ, Tack J, Revicki DA, Rentz AM, Dubois D. Cross-cultural development and validation of a patient self-administered questionnaire to assess quality of life in upper gastrointestinal disorders: the PAGI-QOL. Qual Life Res. 2004 Dec; 13(10):1751-62.
     View PubMed
306. Rentz AM, Kahrilas P, Stanghellini V, Tack J, Talley NJ, de la Loge C, Trudeau E, Dubois D, Revicki DA. Development and psychometric evaluation of the patient assessment of upper gastrointestinal symptom severity index (PAGI-SYM) in patients with upper gastrointestinal disorders. Qual Life Res. 2004 Dec; 13(10):1737-49.
     View PubMed
307. Aro P, Ronkainen J, Storskrubb T, Bolling-Sternevald E, Svardsudd K, Talley NJ, Junghard O, Johansson SE, Wiklund I, Agreus L. Validation of the translation and cross-cultural adaptation into Finnish of the Abdominal Symptom Questionnaire, the Hospital Anxiety and Depression Scale and the Complaint Score Questionnaire. Scand J Gastroenterol. 2004 Dec; 39(12):1201-8.
     View PubMed
308. Aro P, Ronkainen J, Storskrubb T, Bolling-Sternevald E, Carlsson R, Johansson SE, Vieth M, Stolte M, Engstrand L, Talley NJ, Agreus L. Valid symptom reporting at upper endoscopy in a random sample of the Swedish adult general population: the Kalixanda study. Scand J Gastroenterol. 2004 Dec; 39(12):1280-8.
     View PubMed
309. Vege SS, Locke GR, Weaver AL, Farmer SA, Melton LJ, Talley NJ. Functional gastrointestinal disorders among people with sleep disturbances: A population-based study. Mayo Clin Proc. 2004 Dec; 79(12):1501-6.
     View PubMed
310. Talley NJ. Management of chronic constipation. Reviews in Gastroenterological Disorders. 2004 Win; 4(1):18-24.
311. Moayyedi P, Delaney BC, Vakil N, Forman D, Talley NJ. The efficacy of proton pump inhibitors in nonulcer dyspepsia: A systematic review and economic analysis. Gastroenterology. 2004 Nov; 127(5):1329-37.
     View PubMed
312. Cremonini F, Talley NJ. Review article: the overlap between functional dyspepsia and irritable bowel syndrome a tale of one or two disorders. Aliment Pharmacol Ther. 2004 Nov; 20(Suppl 7):40-9.
     View PubMed
313. Eslick GD, Talley NJ. Non-cardiac chest pain: predictors of health care seeking, the types of health care professional consulted, work absenteeism and interruption of daily activities. Alimentary Pharmacology & Therapeutics. 2004 Oct 15; 20(8):909-15.
     View PubMed
314. Cremonini F, Talley NJ. Diagnostic and therapeutic strategies in the irritable bowel syndrome. Minerva Med. 2004 Oct; 95(5):427-41.
     View PubMed
315. Crowell MD, Lacy BE, Schettler VA, Dineen TN, Olden KW, Talley NJ. Subtypes of anal incontinence associated with bowel dysfunction: Clinical, physiologic, and psychosocial characterization. Dis Colon Rectum. 2004 Oct; 47(10):1627-35.
     View PubMed
316. Rohrbock RBK, Hammer J, Vogelsang H, Talley NJ, Hammer HF. Acupuncture has a placebo effect on rectal perception but not on distensibility and spatial summation: A study in health and IBS. Am J Gastroenterol. 2004 Oct; 99(10):1990-7.
     View PubMed
317. Talley NJ, Vakil N, Delaney B, Marshall B, Bytzer P, Engstrand L, de Boer W, Jones R, Malfertheiner P, Agreus L. Management issues in dyspepsia: Current consensus and controversies. Scand J Gastroenterol. 2004 Oct; 39(10):913-8.
     View PubMed
318. Haag S, Talley NJ, Holtmann G. Symptom patterns in functional dyspepsia and irritable bowel syndrome: relationship to disturbances in gastric emptying and response to a nutrient challenge in consulters and non-consulters. Gut. 2004 Oct; 53(10):1445-51.
     View PubMed
319. Talley NJ. Practical examples: trials and conclusions - an interactive segment. Alimentary Pharmacology & Therapeutics. 2004 Oct; 20(Suppl 5):9-13.
     View PubMed
320. Talley NJ. Gastro-oesophageal reflux disease - how wide is its span? Alimentary Pharmacology & Therapeutics. 2004 Oct; 20(Suppl 5):27-37.
     View PubMed
321. Dent J, Talley NJ. Clinical strategies - interactive case discussions. Alimentary Pharmacology & Therapeutics. 2004 Oct; 20(Suppl 5):97-104.
     View PubMed
322. Nandurkar S, Locke GR, Fett S, Zinsmeister AR, Cameron AJ, Talley NJ. Relationship between body mass index, diet, exercise and gastro-oesophageal reflux symptoms in a community. Aliment Pharmacol Ther. 2004 Sep 1; 20(5):497-505.
     View PubMed
323. Friedrich WN, Whiteside SP, Talley NJ. Noncoercive sexual contact with similarly aged individuals: what is the impact? Journal of Interpersonal Violence. 2004 Sep; 19(9):1075-84.
     View PubMed
324. Delgado-Aros S, Locke GR, Camilleri M, Talley NJ, Fett S, Zinsmeister AR, Melton LJ. Obesity is associated with increased risk of gastrointestinal symptoms: A population-based study. Am J Gastroenterol. 2004 Sep; 99(9):1801-6.
     View PubMed
325. Talley NJ, Howell S, Poulton R. Obesity and chronic gastrointestinal tract symptoms in young adults: A birth cohort study. Am J Gastroenterol. 2004 Sep; 99(9):1807-14.
     View PubMed
326. Armstrong D, Talley NJ, Lauritsen K, Moum B, Lind T, Tunturi-Hihnala H, Venables T, Green J, Bigard MA, Mossner J, Junghard O. The role of acid suppression in patients with endoscopy-negative reflux disease: the effect of treatment with esomeprazole or omeprazole. Alimentary Pharmacology & Therapeutics. 2004 Aug 15; 20(4):413-21.
     View PubMed
327. Howell S, Talley NJ, Quine S, Poulton R. The irritable bowel syndrome has origins in the childhood socioeconomic environment. Am J Gastroenterol. 2004 Aug; 99(8):1572-8.
     View PubMed
328. Cremonini F, Delgado-Aros S, Talley NJ. Functional dyspepsia: drugs for new (and old) therapeutic targets. Best Pract Res Clin Gastroenterol. 2004 Aug; 18(4):717-33.
     View PubMed
329. Talley NJ, Quan C, Jones MP, Horowitz M. Association of upper and lower gastrointestinal tract symptoms with body mass index in an Australian cohort. Neurogastroenterol Motil. 2004 Aug; 16(4):413-9.
     View PubMed
330. Talley NJ. What the physician needs to know for correct management of gastro-oesophageal reflux disease and dyspepsia. Alimentary Pharmacology & Therapeutics. 2004 Jul; 20(Suppl 2):23-30.
     View PubMed
331. Locke GR, Yawn BP, Wollan PC, Melton LJ, Lydick E, Talley NJ. Incidence of a clinical diagnosis of the irritable bowel syndrome in a United States population. Aliment Pharmacol Ther. 2004 May 1; 19(9):1025-31.
     View PubMed
332. Hammer J, Eslick GD, Howell SC, Altiparmak E, Talley NJ. Diagnostic yield of alarm features in irritable bowel syndrome and functional dyspepsia. Gut. 2004 May 1; 53(5):666-72.
     View PubMed
333. Dent J, Armstrong D, Delaney B, Moayyedi P, Talley NJ, Vakil N. Symptom evaluation in reflux disease: workshop background, processes, terminology, recommendations, and discussion outputs. Gut. 2004 May; 53(Suppl 4):1-24.
     View PubMed
334. Revicki DA, Rentz AM, Dubois D, Kahrilas P, Stanghellini V, Talley NJ, Tack J. Gastroparesis Cardinal Symptom Index (GCSI): development and validation of a patient reported assessment of severity of gastroparesis symptoms. Qual Life Res. 2004 May; 13(4):833-44.
     View PubMed
335. Holtmann G, Kutscher SU, Haag S, Langkafel M, Heuft G, Neufang-Hueber J, Goebell H, Senf W, Talley NJ. Clinical presentation and personality factors are predictors of the response to treatment in patients with functional dyspepsia - A randomized, double-blind placebo-controlled crossover study. Dig Dis Sci. 2004 Apr; 49(4):672-9.
     View PubMed
336. Locke GR, Murray JA, Zinsmeister AR, Melton LJ, Talley NJ. Celiac disease serology in irritable bowel syndrome and dyspepsia: A population-based case-control study. Mayo Clin Proc. 2004 Apr; 79(4):476-82.
     View PubMed
337. Holtmann G, Siffert W, Haag S, Mueller N, Langkafel M, Senf W, Zotz R, Talley NJ. G-protein beta 3 subunit 825 CC genotype is associated with unexplained (functioncal) dyspepsia. Gastroenterology. 2004 Apr; 126(4):971-9.
     View PubMed
338. Camilleri M, Talley NJ. Pathophysiology as a basis for understanding symptom complexes and therapeutic targets. Neurogastroenterol Motil. 2004 Apr; 16(2):135-42.
     View PubMed
339. Fock KM, Talley N, Hunt R, Fass R, Nandurkar S, Lam SK, Goh KL, Sollano J. Report of the Asia-Pacific consensus on the management of gastroesophageal reflux disease. J Gastroenterol Hepatol. 2004 Apr; 19(4):357-67.
     View PubMed
340. El-Serag HB, Talley NJ. Systematic review: The prevalence and clinical course of functional dyspepsia. Aliment Pharmacol Ther. 2004 Mar 15; 19(6):643-54.
     View PubMed
341. Locke GR, Weaver AL, Melton LJ, Talley NJ. Psychosocial factors are linked to functional gastrointestinal disorders: A population based nested case-control study. Am J Gastroenterol. 2004 Feb; 99(2):350-7.
     View PubMed
342. Halder SLS, Locke GR, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ. Impact of functional gastrointestinal disorders on health-related quality of life: a population-based case-control study. Aliment Pharmacol Ther. 2004 Jan 15; 19(2):233-42.
     View PubMed
343. Eslick GD, Howell SC, Hammer J, Talley NJ. Empirically derived symptom sub-groups correspond poorly with diagnostic criteria for functional dyspepsia and irritable bowel syndrome. A factor and cluster analysis of a patient sample. Aliment Pharmacol Ther. 2004 Jan 1; 19(1):133-40.
     View PubMed
344. Crowell MD, Shetzline MA, Moses PL, Mawe GM, Talley NJ. Enterochromaffin cells and 5-HT signaling in the pathophysiology of disorders of gastrointestinal function. Curr Opin Investig Drugs. 2004 Jan; 5(1):55-60.
     View PubMed
345. Talley NJ. Irritable bowel syndrome remains a difficult condition to manage. Drug Benefit Trends. 2004; 16(6):313-22.
346. Talley NJ. Definitions, epidemiology, and impact of chronic constipation. Reviews in Gastroenterological Disorders. 2004; 4(Suppl 2):S3-S10.
     View PubMed
347. Delgado-Aros S, Cremonini F, Talley NJ. Treatment of functional dyspepsia. Curr Treat Options Gastroenterol. 2004; 7(2):121-31.
     View PubMed
348. Mearin F, Roset M, Badia X, Balboa A, Baro E, Ponce J, Diaz-Rubio M, Caldwell E, Cucala M, Fueyo A, Talley NJ. Splitting Irritable Bowel Syndrome: From Original Rome to Rome II Criteria. American Journal of Gastroenterology. 2004; 99:122-130.
     View PubMed
349. Peura DA, Kovacs TO, Metz DC, Siepman N, Pilmer BL, Talley NJ. Lansoprazole in the treatment of functional dyspepsia: two double-blind, randomized, placebo-controlled trials. American Journal of Medicine. 2004; 116:740-8.
     View PubMed
350. De la Loge C, Trudeau E, Marquis P, Revicki D, Rentz AM, Stanghellini V, Talley NJ, Kahrilas P, Tack J, Dubois D. Responsiveness and interpretation of a quality of life questionnaire specific to upper-gastrointestinal disorders. Clinical Gastroenterology and Hepatology. 2004; 2:778-786.
     View PubMed
351. Revicki DA, Rentz AM, Tack J, Stanghellini V, Talley NJ, Kahrilas P, de la Loge C, Trudeau E, Dubois D. Responsiveness and interpretation of the patient assessment of Gastrointestinal Symptom Severity Index (PAGI-SYM). Clinical Gastroenterology and Hepatology. 2004; 2:769-77.
     View PubMed
352. Xia HHX, Wong BCY, Zhang GS, Yang Y, Wyatt JM, Adams S, Cheung K, Lam SK, Talley NJ. Antralization of gastric incisura is topographically associated with increased gastric epithelial apoptosis and proliferation, but not with CagA seropositivity. Journal of Gastroenterology & Hepatology. 2004; 19:1257-63.
     View PubMed
353. Feinle-Bisset C, Vozzo R, Horowitz M, Talley NJ. Diet, food intake and disturbed physiology in the pathogenesis of symptoms in functional dyspepsia. American Journal of Gastroenterology. 2004; 99:17081.
     View PubMed
354. Talley NJ. Functional gastrointestinal disorders. DDW Reviews in Gastroenterological Disorders 2004 Review; 4:144-146.
355. Kalantar JS, Locke GR, Zinsmeister AR, Beighley CM, Talley NJ. Familial aggregation of irritable bowel syndrome: a prospective study. Gut. 2003 Dec 1; 52(12):1703-7.
     View PubMed
356. Saito YA, Talley NJ, Melton LJ, Fett S, Zinsmeister AR, Locke GR. The effect of new diagnostic criteria for irritable bowel syndrome on community prevalence estimates. Neurogastroenterol Motil. 2003 Dec; 15(6):687-94.
     View PubMed
357. Talley NJ, Dennis EH, Schettler-Duncan VA, Lacy BE, Olden KW, Crowell MD. Overlapping upper and lower gastrointestinal symptoms in irritable bowel syndrome patients with constipation or diarrhea. Am J Gastroenterol. 2003 Nov; 98(11):2454-9.
     View PubMed
358. Locke GR, Zinsmeister AR, Talley NJ. Can symptoms predict endoscopic findings in GERD? Gastrointest Endosc. 2003 Nov; 58(5):661-70.
     View PubMed
359. Talley NJ. Evaluation of drug treatment in irritable bowel syndrome. Br J Clin Pharmacol. 2003 Oct; 56(4):362-9.
     View PubMed
360. Talley NJ. Dyspepsia. Gastroenterology. 2003 Oct; 125(4):1219-26.
     View PubMed
361. Boyce PM, Talley NJ, Balaam B, Koloski NA, Truman G. A randomized controlled trial of cognitive behavior therapy, relaxation training, and routine clinical care for the irritable bowel syndrome. Am J Gastroenterol. 2003 Oct; 98(10):2209-18.
     View PubMed
362. El-Serag HB, Talley NJ. Systematic review: health-related quality of life in functional dyspepsia. Alimentary Pharmacology & Therapeutics. 2003 Aug 15; 18(4):387-93.
     View PubMed
363. Kalantar JS, Locke GR, Talley NJ, Zinsmeister AR, Fett SL, Melton LJ. Is irritable bowel syndrome more likely to be persistent in those with relatives who suffer from gastrointestinal symptoms? A population-based study at three time points. Aliment Pharmacol Ther. 2003 Jun 1; 17(11):1389-97.
     View PubMed
364. Westbrook JI, Talley NJ. Diagnostic investigation rates and use of prescription and non-prescription medications amongst dyspeptics: a population-based study of 2300 Australians. Aliment Pharmacol Ther. 2003 May 1; 17(9):1171-8.
     View PubMed
365. Talley NJ, Jones M, Nuyts G, Dubois D. Risk factors for chronic constipation based on a general practice sample. Am J Gastroenterol. 2003 May; 98(5):1107-11.
     View PubMed
366. Xia HHX, Talley NJ, Blum AL, O'Morain CA, Stolte M, Bolling-Sternevald E, Mitchell HM. Clinical and pathological implications of IgG antibody responses to Helicobacter pylori and its virulence factors in non-ulcer dyspepsia. Alimentary Pharmacology & Therapeutics. 2003 Apr 1; 17(7):935-43.
     View PubMed
367. Talley NJ. Pharmacologic therapy for the irritable bowel syndrome. Am J Gastroenterol. 2003 Apr; 98(4):750-8.
     View PubMed
368. Koloski NA, Talley NJ, Boyce PM. Does psychological distress modulate functional gastrointestinal symptoms and health care seeking? A prospective, community Cohort study. Am J Gastroenterol. 2003 Apr; 98(4):789-97.
     View PubMed
369. Hammer J, Howell S, Bytzer P, Horowitz M, Talley NJ. Symptom clustering in subjects with and without diabetes mellitus: a population-based study of 15000 Australian adults. Am J Gastroenterol. 2003 Feb; 98(2):391-8.
     View PubMed
370. Talley NJ. Diabetic gastropathy and prokinetics. Am J Gastroenterol. 2003 Feb; 98(2):264-71.
     View PubMed
371. Koloski NA, Talley NJ, Huskic SS, Boyce PM. Predictors of conventional and alternative health care seeking for irritable bowel syndrome and functional dyspepsia. Alimentary Pharmacology and Therapeutics. 2003; 17:841-51.
     View PubMed
372. Talley NJ. Omeprazole was effective in the short term for uninvestigated dyspepsia ACP J Club. 2003; 138:1-3.
373. Weltman M, Talley NJ. An approach to recurrent, non-identifiable GI bleeding. New Ethicals Journal. 2003; New Ethicals Journal. 2003:57-63.
374. Cremonini F, Talley NJ. Commentary – The cost-effectiveness of psychotherapy and paroxetine for severe irritable bowel syndrome by Creed F, Fernandes L, Guthrie E, et al. Br Med J. 2003; 8:160.
375. Howe SC, Quine S, Talley NJ. Ethics review and use of reminder letters in postal surveys: are current practices comprising an evidence-based approach? Med J Aust. 2003; 178:43.
     View PubMed
376. Talley NJ. When to conduct testing in patients with suspected irritable bowel syndrome. Reviews in Gastroenterological Disorders. 2003; 3 Suppl 3:S18-24.
     View PubMed
377. Talley NJ. Functional Disorders. Target the brain to get the gain? Reviews in Gastrointestinal Disorders. 2003; 3:182-4.
378. Talley NJ. Best of DDW 2003. New insights on treatment of irritable bowel syndrome and functional dyspepsia Reviews in Gastroenterological Disorders. 2003; 3:172-5.
379. Talley NJ. Update on the Role of Drug Therapy in Non-Ulcer Dyspepsia. Reviews in Gastroenterological Disorders. 2003; 3:25-30.
     View PubMed
380. Wiklund I, Talley NJ. Update on health-related quality of life in patients with gastroesophageal reflux disease (GERD). Expert Rev Pharmacoeconomics & Outcomes Research. 2003; 3:341-50.
381. Dent J, Talley NJ. Overview: initial and long-term management of gastro-oesophageal reflux disease. Alimentary Pharmacology and Therapeutics. 2003; 1(17 Suppl):53-7.
382. Weltman MD, Talley NJ. Chronic hepatitis C infection: a review and update on treatment strategies. ADF Health. 2003; 4:27-33.
383. Moayyedi P, Deeks J, Talley NJ, Delaney B, Forman D. An update of the Cochrane systematic review of Helicobactor pylori eradication therapy in non-ulcer dyspepsia. Resolving the discrepancy between systematic reviews. American Journal of Gastroenterology. 2003; 98(12):2621-2626.
     View PubMed
384. Talley NJ. Helicobacter pylori management: how to improve the therapeutic confusion in practice. Canadian Journal of Gastroenterology. 2003; B:21B-24B.
385. Müller-Lissner S, Koch G, Talley NJ, Drossman D, Rueegg P, Dunger-Baldauf C, Lefkowitz M. Subject’s global assess (SGA) of relief: an appropriate method to assess the impact of treatment on irritable bowel syndrome-related symptoms in clinical trials. Journal of Clinical Epidemiology. 2003; 56:310-16.
     View PubMed
386. Eslick GD, Jones MP, Talley NJ. Non-cardiac chest pain: prevalence, risk factors, impact and consulting – a population-based study. Alimentary Pharmacology and Therapeutics. 2003; 17:1115-1124.
     View PubMed
387. Quan C, Talley NJ, Cross S, Jones M, Hammer J, Giles N, Horowitz M. Development and validation of the diabetes bowel symptom questionnaire. Alimentary Pharmacology and Therapeutics. 2003; 17:1179-1187.
     View PubMed
388. Revicki DA, Rentz AM, Dubois D, Kahrilas P, Stanghellini V, Talley NJ, Tack J. Development and validation of a patient assessed gastroparesis symptom severity measure: the gastroparesis cardinal symptom index (GCSI). Alimentary Pharmacology and Therapeutics. 2003; 18:141-50.
     View PubMed
389. Bolling-Sternevald E, Lauritsen K, Talley NJ, Junghard O, Glise H. Is it possible to predict treatment response to a proton pump inhibitor in functional dyspepsia? Alimentary Pharmacology and Therapeutics. 2003; 18:117-124.
     View PubMed
390. Howell S, Poulton R, Caspi A, Talley NJ. Relationship between abdominal pain subgroups in the community and psychiatric diagnosis and personality. A birth cohort study Journal of Psychosomatic Research. 2003; 55:179-87.
391. Mearin F, Balboa A, Badia X, Baro E, Caldwell E, Cucala M, Diaz-Rubio M, Fueyo A, Ponce J, Roset M, Talley NJ. Irritable bowel syndrome subtypes according to bowel habit: revisiting the alternating subtype. European Journal of Gastorenterology and Hepatology. 2003; 15:165-72.
392. Xia HH, Zhang GS, Talley NJ, Wong BC, Yang Y, Henwood C, Wyatt JM, Adams S, Cheung K, Xia B, Zhu YQ, Lam SK. Topographic association of gastric epithelial expression of Ki-67, Bax, and Bcl-2 with antralization in the gastric incisura, body, and fundus. Am J Gastroenterol. 2002 Dec; 97(12):3023-31.
     View PubMed
393. Talley NJ, Howell S, Jones MP, Horowitz M. Predictors of turnover of lower gastrointestinal symptoms in diabetes mellitus. Am J Gastroenterol. 2002 Dec; 97(12):3087-94.
     View PubMed
394. Quan C, Talley NJ. Management of peptic ulcer disease not related to Helicobacter pylori or NSAIDs. Am J Gastroenterol. 2002 Dec; 97(12):2950-61.
     View PubMed
395. Katelaris PH, Forbes GM, Talley NJ, Crotty B. A randomized comparison of quadruple and triple therapies for Helicobacter pylori eradication: The QUADRATE Study. Gastroenterology. 2002 Dec; 123(6):1763-9.
     View PubMed
396. Holtmann G, Gschossmann J, Buenger L, Gerken G, Talley NJ. Do changes in visceral sensory function determine the development of dyspepsia during treatment with aspirin? Gastroenterology. 2002 Nov; 123(5):1451-8.
     View PubMed
397. Talley NJ, Moore MG, Sprogis A, Katelaris P. Randomised controlled trial of pantoprazole versus ranitidine for the treatment of uninvestigated heartburn in primary care. Med J Aust. 2002 Oct 21; 177(8):423-7.
     View PubMed
398. Jones MP, Talley NJ, Nuyts G, Dubois D. Lack of objective evidence of efficacy of laxatives in chronic constipation. Dig Dis Sci. 2002 Oct; 47(10):2222-30.
     View PubMed
399. Eslick GD, Yan P, Xia HH, Murray H, Spurrett B, Talley NJ. Foetal intrauterine growth restrictions with Helicobacter pylori infection. Aliment Pharmacol Ther. 2002 Sep; 16(9):1677-82.
     View PubMed
400. Holtmann G, Gschossmann J, Mayr P, Talley NJ. A randomized placebo-controlled trial of simethicone and cisapride for the treatment of patients with functional dyspepsia. Aliment Pharmacol Ther. 2002 Sep; 16(9):1641-8.
     View PubMed
401. Koloski NA, Talley NJ, Boyce PM. Epidemiology and health care seeking in the functional GI disorders: a population-based study. Am J Gastroenterol. 2002 Sep; 97(9):2290-9.
     View PubMed
402. Talley NJ, Venables TL, Green JR, Armstrong D, O'Kane KP, Giaffer M, Bardhan KD, Carlsson RG, Chen S, Hasselgren GS. Esomeprazole 40 mg and 20 mg is efficacious in the long-term management of patients with endoscopy-negative gastro-oesophageal reflux disease: a placebo-controlled trial of on-demand therapy for 6 months. Eur J Gastroenterol Hepatol. 2002 Aug; 14(8):857-63.
     View PubMed
403. Westbrook JI, Talley NJ. Empiric clustering of dyspepsia into symptom subgroups: a population-based study. Scand J Gastroenterol. 2002 Aug; 37(8):917-23.
     View PubMed
404. Westbrook JI, Talley NJ, Westbrook MT. Gender differences in the symptoms and physical and mental well-being of dyspeptics: a population based study. Qual Life Res. 2002 May; 11(3):283-91.
     View PubMed
405. Veldhuyzen van Zanten SJ, Talley NJ, Blum AL, Bolling-Sternevald E, Sundin M, Junghard O. Combined analysis of the ORCHID and OCAY studies: does eradication of Helicobacter pylori lead to sustained improvement in functional dyspepsia symptoms? Gut. 2002 May; 50(Suppl 4):iv26-30; discussion iv31-2.
     View PubMed
406. Talley NJ. Dyspepsia: management guidelines for the millennium. Gut. 2002 May; 50(Suppl 4):iv72-8; discussion iv79.
     View PubMed
407. Talley NJ, Lauritsen K. The potential role of acid suppression in functional dyspepsia: the BOND, OPERA, PILOT, and ENCORE studies. Gut. 2002 May; 50(Suppl 4):iv36-41.
     View PubMed
408. Jones KL, Wishart JM, Berry M, Russo A, Xia HH, Talley NJ, Horowitz M. Helicobacter pylori infection is not associated with delayed gastric emptying or upper gastrointestinal symptoms in diabetes mellitus. Dig Dis Sci. 2002 Apr; 47(4):704-9.
     View PubMed
409. Bytzer P, Talley NJ, Hammer J, Young LJ, Jones MP, Horowitz M. GI symptoms in diabetes mellitus are associated with both poor glycemic control and diabetic complications. Am J Gastroenterol. 2002 Mar; 97(3):604-11.
     View PubMed
410. Kalantar JS, Howell S, Talley NJ. Prevalence of faecal incontinence and associated risk factors: an underdiagnosed problem in the Australian community? Med J Aust. 2002 Jan 21; 176(2):54-7.
     View PubMed
411. Badia X, Mearin F, Balboa A, Baro E, Caldwell E, Cucala M, Diaz-Rubio M, Fueyo A, Ponce J, Roset M, Talley NJ. Burden of illness in irritable bowel syndrome comparing Rome I and Rome II criteria. Pharmacoeconomics. 2002; 20(11):749-58.
     View PubMed
412. Talley NJ, Spiller R. Irritable bowel syndrome: a little understood organic bowel disease? Lancet. 2002; 360:555-64.
     View PubMed
413. Talley NJ. Dyspepsia management in the millennium: the death of test and treat? Gastroenterology. 2002; 122:1521-5.
     View PubMed
414. Eslick GD, Coulshed DS, Talley NJ. The burden of illness of non-cardiac chest pain. Aliment Pharmacol Ther. 2002; 16:1217-23.
     View PubMed
415. Talley NJ. Dyspepsia: how to manage and how to treat? Aliment Pharmacol Ther. 2002; 16(Suppl 4):95-104.
     View PubMed
416. Talley NJ, Quan C. Helicobacter pylori and non-ulcer dyspepsia. Aliment Pharmacol Ther. 2002; 16(Suppl 1):58-65.
     View PubMed
417. Jones R, Dent J, Kahrilas P, Talley NJ. Management of gastro-oesphageal reflux disease in general practice. Br Med J. 2002; 322:344-7.
418. Weltmann MD, Talley NJ. An approach to recurrent non-identifiable GI bleeding. Curr Ther. 2002; 43:27-35.
419. Coulshed DS, Eslick GD, Talley NJ. Non-cardiac chest pain: patients need diagnoses? Br Med J. 2002; 324:915.
     View PubMed
420. Friedrich WN, Whiteside SP, Talley NJ. A research perspective on the compliant child victim. APSAC Advisor. 2002; 14(2):19-20.
421. Waldum HL, Brenna E, Alberti H, Jones R, Dent J, Kahrilas P, Talley NJ. Gastro-oesphageal reflux disease in general practice. Br Med J. 2002; 324:485.
422. Axon A, Talley NJ, Veldhuyzen Van Zanten SJ. pH-Hp: implications for dyspepsia management. Gut. 2002; 50(Suppl 4):iv1.
     View PubMed
423. Bennett G, Talley NJ. Irritable bowel syndrome in the elderly. Best Practice of Clinical Gastroenterology. 2002; 16:63-76.
424. Talley NJ, Abeygunasekera S. Bile reflux and Barrett's oesophagus: innocent bystander or sinister companion? Digestive and Liver Disease. 2002; 34:246-8.
     View PubMed
425. Abeygunasekera S, Talley NJ. Management of dysepsia. Comprehensive Therapy. 2002; 28:182-9.
     View PubMed
426. Xia HH, Yu Wong BC, Talley NJ, Lam SK. Alternative and rescue treatment regimens for Helicobacter pylori eradication. Expert Opin Pharmacother. 2002; 3:1301-11.
     View PubMed
427. Talley NJ. Serotoninergic neuroenteric modulators. Lancet. 2001 Dec 15; 358(9298):2061-8.
     View PubMed
428. Xia HH, Phung N, Altiparmak E, Berry A, Matheson M, Talley NJ. Reduction of peptic ulcer disease and Helicobacter pylori infection but increase of reflux esophagitis in Western Sydney between 1990 and 1998. Dig Dis Sci. 2001 Dec; 46(12):2716-23.
     View PubMed
429. Mearin F, Badia X, Balboa A, Baro E, Caldwell E, Cucala M, Diaz-Rubio M, Fueyo A, Ponce J, Roset M, Talley NJ. Irritable bowel syndrome prevalence varies enormously depending on the employed diagnostic criteria: comparison of Rome II versus previous criteria in a general population. Scand J Gastroenterol. 2001 Nov; 36(11):1155-61.
     View PubMed
430. Agreus L, Svardsudd K, Talley NJ, Jones MP, Tibblin G. Natural history of gastroesophageal reflux disease and functional abdominal disorders: a population-based study. Am J Gastroenterol. 2001 Oct; 96(10):2905-14.
     View PubMed
431. Levy RL, Jones KR, Whitehead WE, Feld SI, Talley NJ, Corey LA. Irritable bowel syndrome in twins: heredity and social learning both contribute to etiology. Gastroenterology. 2001 Oct; 121(4):799-804.
     View PubMed
432. Talley NJ, Riff DS, Schwartz H, Marcuard SP. Double-blind placebo-controlled multicentre studies of rebamipide, a gastroprotective drug, in the treatment of functional dyspepsia with or without Helicobacter pylori infection. Aliment Pharmacol Ther. 2001 Oct; 15(10):1603-11.
     View PubMed
433. Bytzer P, Talley NJ, Leemon M, Young LJ, Jones MP, Horowitz M. Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15,000 adults. Arch Intern Med. 2001 Sep 10; 161(16):1989-96.
     View PubMed
434. Talley NJ, Verlinden M, Geenen DJ, Hogan RB, Riff D, McCallum RW, Mack RJ. Effects of a motilin receptor agonist (ABT-229) on upper gastrointestinal symptoms in type 1 diabetes mellitus: a randomised, double blind, placebo controlled trial. Gut. 2001 Sep; 49(3):395-401.
     View PubMed
435. Talley NJ. Irritable bowel syndrome. Best Practice of Medicine. 2001 Sep.
436. Bytzer P, Howell S, Leemon M, Young LJ, Jones MP, Talley NJ. Low socioeconomic class is a risk factor for upper and lower gastrointestinal symptoms: a population based study in 15 000 Australian adults. Gut. 2001 Jul; 49(1):66-72.
     View PubMed
437. Holtmann G, Gschossmann J, Holtmann M, Talley NJ. H. pylori and functional dyspepsia: increased serum antibodies as an independent risk factor? Dig Dis Sci. 2001 Jul; 46(7):1550-7.
     View PubMed
438. Talley NJ, Fullerton S, Junghard O, Wiklund I. Quality of life in patients with endoscopy-negative heartburn: reliability and sensitivity of disease-specific instruments. Am J Gastroenterol. 2001 Jul; 96(7):1998-2004.
     View PubMed
439. Shaw MJ, Beebe TJ, Adlis SA, Talley NJ. Reliability and validity of the digestive health status instrument in samples of community, primary care, and gastroenterology patients. Aliment Pharmacol Ther. 2001 Jul; 15(7):981-7.
     View PubMed
440. Talley NJ. Drug therapy options for patients with irritable bowel syndrome. Am J Manag Care. 2001 Jul; 7(8 Suppl):S261-7.
     View PubMed
441. Bytzer P, Talley NJ. Current indications for acid suppressants in dyspepsia. Best Pract Res Clin Gastroenterol. 2001 Jun; 15(3):385-400.
     View PubMed
442. Talley NJ, Thitiphuree S. Lump or split dyspepsia? A continuing controversy. Curr Gastroenterol Rep. 2001 Jun; 3(3):175-6.
     View PubMed
443. Bytzer P, Talley NJ. Dyspepsia. Ann Intern Med. 2001 May 1; 134(9 Pt 2):815-22.
     View PubMed
444. Talley NJ, Verlinden M, Jones M. Can symptoms discriminate among those with delayed or normal gastric emptying in dysmotility-like dyspepsia? Am J Gastroenterol. 2001 May; 96(5):1422-8.
     View PubMed
445. Koloski NA, Talley NJ, Boyce PM. Predictors of health care seeking for irritable bowel syndrome and nonulcer dyspepsia: a critical review of the literature on symptom and psychosocial factors. Am J Gastroenterol. 2001 May; 96(5):1340-9.
     View PubMed
446. Talley SJ, Bytzer P, Hammer J, Young L, Jones M, Horowitz M. Psychological distress is linked to gastrointestinal symptoms in diabetes mellitus. Am J Gastroenterol. 2001 Apr; 96(4):1033-8.
     View PubMed
447. McManis PG, Newall D, Talley NJ. Abdominal wall muscle activity in irritable bowel syndrome with bloating. Am J Gastroenterol. 2001 Apr; 96(4):1139-42.
     View PubMed
448. Talley NJ, Howell S, Poulton R. The irritable bowel syndrome and psychiatric disorders in the community: is there a link? Am J Gastroenterol. 2001 Apr; 96(4):1072-9.
     View PubMed
449. Talley NJ, Van Zanten SV, Saez LR, Dukes G, Perschy T, Heath M, Kleoudis C, Mangel AW. A dose-ranging, placebo-controlled, randomized trial of alosetron in patients with functional dyspepsia. Aliment Pharmacol Ther. 2001 Apr; 15(4):525-37.
     View PubMed
450. Xia HH, Talley NJ, Kam EP, Young LJ, Hammer J, Horowitz M. Helicobacter pylori infection is not associated with diabetes mellitus, nor with upper gastrointestinal symptoms in diabetes mellitus. Am J Gastroenterol. 2001 Apr; 96(4):1039-46.
     View PubMed
451. Shaw MJ, Fendrick AM, Kane RL, Adlis SA, Talley NJ. Self-reported effectiveness and physician consultation rate in users of over-the-counter histamine-2 receptor antagonists. Am J Gastroenterol. 2001 Mar; 96(3):673-6.
     View PubMed
452. Talley NJ, Lauritsen K, Tunturi-Hihnala H, Lind T, Moum B, Bang C, Schulz T, Omland TM, Delle M, Junghard O. Esomeprazole 20 mg maintains symptom control in endoscopy-negative gastro-oesophageal reflux disease: a controlled trial of 'on-demand' therapy for 6 months. Aliment Pharmacol Ther. 2001 Mar; 15(3):347-54.
     View PubMed
453. Veldhuyzen van Zanten SJ, Jones MJ, Verlinden M, Talley NJ. Efficacy of cisapride and domperidone in functional (nonulcer) dyspepsia: a meta-analysis. Am J Gastroenterol. 2001 Mar; 96(3):689-96.
     View PubMed
454. Talley NJ, Verlinden M, Jones M. Quality of life in functional dyspepsia: responsiveness of the Nepean Dyspepsia Index and development of a new 10-item short form. Aliment Pharmacol Ther. 2001 Feb; 15(2):207-16.
     View PubMed
455. Xia HH, Yu Wong BC, Talley NJ, Lam SK. Helicobacter pylori infection--current treatment practice. Expert Opin Pharmacother. 2001 Feb; 2(2):253-66.
     View PubMed
456. Talley NJ, Young L, Bytzer P, Hammer J, Leemon M, Jones M, Horowitz M. Impact of chronic gastrointestinal symptoms in diabetes mellitus on health-related quality of life. Am J Gastroenterol. 2001 Jan; 96(1):71-6.
     View PubMed
457. Shaw MJ, Talley NJ, Beebe TJ, Rockwood T, Carlsson R, Adlis S, Fendrick AM, Jones R, Dent J, Bytzer P. Initial validation of a diagnostic questionnaire for gastroesophageal reflux disease. Am J Gastroenterol. 2001 Jan; 96(1):52-7.
     View PubMed
458. Bytzer P, Talley NJ, Jones MP, Horowitz M. Oral hypoglycaemic drugs and gastrointestinal symptoms in diabetes mellitus. Aliment Pharmacol Ther. 2001 Jan; 15(1):137-42.
     View PubMed
459. Xia HH, Talley NJ. Apoptosis in gastric epithelium induced by Helicobacter pylori infection: implications in gastric carcinogenesis. Am J Gastroenterol. 2001 Jan; 96(1):16-26.
     View PubMed
460. Talley NJ. Metholdogical issues in irritable bowel syndrome clinical trials: practical relevance for the clinician. Practical Gastroenterology. 2001; 8:16-23.
461. Talley NJ. Dealing with patients' concerns and expectations. Eur J Gastroenterol Hepatol. 2001; 13(Suppl 3):S5-6.
462. Talley NJ. Should oesophagitis be healed? Eur J Gastroenterol Hepatol. 2001; 13(Suppl 3):S36-7.
463. Talley NJ. Efficacies of different proton pump inhibitors in reflux disease. Eur J Gastroenterol Hepatol. 2001; 13(Suppl 3):S55-6.
464. Talley NJ. When and why should empirically treated patients have endoscopy? Eur J Gastroenterol Hepatol. 2001; 13(Suppl 3):S75-6.
465. Talley NJ, Phung N, Kalantar JS. ABC of the upper gastrointestinal tract: indigestion: when is it functional? Br Med J. 2001; 323:1294-7.
466. Dent J, Jones R, Kahrilas PJ, Talley NJ. Management of gastro-oesophageal reflux disease in general practice. Br Med J. 2001; 322:344-47.
467. Talley NJ. Commentary on "Community screening for Helicobacter pylori does not improve quality of life.". Evidence Based Healthcare. 2001; 5:7.
468. Talley NJ. Therapeutic options in nonulcer dyspepsia. J Clin Gastroenterol. 2001; 96:673-6.
469. Boyce P, Hickey A, Gilchrist J, Talley NJ. The development of a brief personality scale to measure vulnerability to postnatal depression. Archive of Women's Mental Health. 2001; 3:147-53.
470. Bensoussan A, Chang SW, Menzies RG, Talley NJ. Application of the general health status questionnaire SF36 to patients with gastrointestinal dysfunction: initial validation and validation as a measure of change. Aust N Z J Public Health. 2001; 25(1):71-7.
     View PubMed
471. Koloski NA, Talley NJ, Boyce PM, Morris-Yates AD. The effect of questionnaire length and lottery ticket incentive on the response rate in mail surveys. Psychology & Health. 2001; 16:67-75.
472. Westbrook JI, McIntosh J, Talley NJ. Factors associated with consulting medical or non-medical practitioners for dyspepsia: an Australian population-based study. Aliment Pharmacol Ther. 2000 Dec; 14(12):1581-8.
     View PubMed
473. Talley NJ, Verlinden M, Snape W, Beker JA, Ducrotte P, Dettmer A, Brinkhoff H, Eaker E, Ohning G, Miner PB, Mathias JR, Fumagalli I, Staessen D, Mack RJ. Failure of a motilin receptor agonist (ABT-229) to relieve the symptoms of functional dyspepsia in patients with and without delayed gastric emptying: a randomized double-blind placebo-controlled trial. Aliment Pharmacol Ther. 2000 Dec; 14(12):1653-61.
     View PubMed
474. Xia HH, Phung N, Kalantar JS, Talley NJ. Demographic and endoscopic characteristics of patients with Helicobacter pylori positive and negative peptic ulcer disease. Med J Aust. 2000 Nov 20; 173(10):515-9.
     View PubMed
475. Hammer J, Talley NJ. Nonulcer dyspepsia. Curr Opin Gastroenterol. 2000 Nov; 16(6):503-7.
     View PubMed
476. Nandurkar S, Talley NJ. Epidemiology and natural history of reflux disease. Baillieres Best Pract Res Clin Gastroenterol. 2000 Oct; 14(5):743-57.
     View PubMed
477. Saito YA, Locke GR, Talley NJ, Zinsmeister AR, Fett SL, Melton LJ 3rd. A comparison of the Rome and Manning criteria for case identification in epidemiological investigations of irritable bowel syndrome. Am J Gastroenterol. 2000 Oct; 95(10):2816-24.
     View PubMed
478. Locke GR 3rd, Zinsmeister AR, Talley NJ, Fett SL, Melton LJ 3rd. Familial association in adults with functional gastrointestinal disorders. Mayo Clin Proc. 2000 Sep; 75(9):907-12.
     View PubMed
479. Hu WH, Martin CJ, Talley NJ. Intraesophageal acid perfusion sensitizes the esophagus to mechanical distension: a Barostat study. Am J Gastroenterol. 2000 Sep; 95(9):2189-94.
     View PubMed
480. Holtmann G, Gschossmann J, Neufang-Huber J, Gerken G, Talley NJ. Differences in gastric mechanosensory function after repeated ramp distensions in non-consulters with dyspepsia and healthy controls. Gut. 2000 Sep; 47(3):332-6.
     View PubMed
481. Neri M, Laterza F, Howell S, Di Gioacchino M, Festi D, Ballone E, Cuccurullo F, Talley NJ. Symptoms discriminate irritable bowel syndrome from organic gastrointestinal diseases and food allergy. Eur J Gastroenterol Hepatol. 2000 Sep; 12(9):981-8.
     View PubMed
482. Locke GR 3rd, Talley NJ, Nelson DK, Haruma K, Weaver AL, Zinsmeister AR, Melton LJ 3rd. Helicobacter pylori and dyspepsia: a population-based study of the organism and host. Am J Gastroenterol. 2000 Aug; 95(8):1906-13.
     View PubMed
483. Talley NJ, Holtmann G, Agreus L, Jones M. Gastrointestinal symptoms and subjects cluster into distinct upper and lower groupings in the community: a four nations study. Am J Gastroenterol. 2000 Jun; 95(6):1439-47.
     View PubMed
484. Haque M, Wyeth JW, Stace NH, Talley NJ, Green R. Prevalence, severity and associated features of gastro-oesophageal reflux and dyspepsia: a population-based study. N Z Med J. 2000 May 26; 113(1110):178-81.
     View PubMed
485. Xia HH, Kalantar JS, Mitchell HM, Talley NJ. Can helicobacter pylori serology still be applied as a surrogate marker to identify peptic ulcer disease in dyspepsia? Aliment Pharmacol Ther. 2000 May; 14(5):615-24.
     View PubMed
486. Carpenter HA, Talley NJ. The importance of clinicopathological correlation in the diagnosis of inflammatory conditions of the colon: histological patterns with clinical implications. Am J Gastroenterol. 2000 Apr; 95(4):878-96.
     View PubMed
487. Reilly WT, Talley NJ, Pemberton JH, Zinsmeister AR. Validation of a questionnaire to assess fecal incontinence and associated risk factors: Fecal Incontinence Questionnaire. Dis Colon Rectum. 2000 Feb; 43(2):146-53; discussion 153-4.
     View PubMed
488. Xia HH, Kalantar JS, Wyatt JM, Adams S, Cheung K, Eslick GD, Talley NJ. High sensitivity and specificity of a laboratory-based serological test, pylori DTect ELISA, for detection of Helicobacter pylori infection. Diagn Microbiol Infect Dis. 2000 Feb; 36(2):69-74.
     View PubMed
489. Nandurkar S, Talley NJ, Martin CJ, Ng T, Adams S. Esophageal histology does not provide additional useful information over clinical assessment in identifying reflux patients presenting for esophagogastroduodenoscopy. Dig Dis Sci. 2000 Feb; 45(2):217-24.
     View PubMed
490. Agreus L, Talley NJ, Svardsudd K, Tibblin G, Jones MP. Identifying dyspepsia and irritable bowel syndrome: the value of pain or discomfort and bowel habit descriptors. Scand J Gastroenterol. 2000 Feb; 35(2):142-51.
     View PubMed
491. Xia HH, Kalantar JS, Talley NJ, Wyatt JM, Adams S, Chueng K, Mitchell HM. Antral-type mucosa in the gastric incisura, body, and fundus (antralization): a link between Helicobacter pylori infection and intestinal metaplasia? Am J Gastroenterol. 2000 Jan; 95(1):114-21.
     View PubMed
492. Koloski NA, Talley NJ, Boyce PM. The impact of functional gastrointestinal disorders on quality of life. Am J Gastroenterol. 2000 Jan; 95(1):67-71.
     View PubMed
493. Locke GR 3rd, Zinsmeister AR, Talley NJ, Fett SL, Melton LJ III. Risk factors for irritable bowel syndrome: role of analgesics and food sensitivities. Am J Gastroenterol. 2000 Jan; 95(1):157-65.
     View PubMed
494. Talley NJ. Diagnosis and management of non-ulcer dyspepsia. Primary Care Reports 6(1) 2000 Jan.
495. Pantoflickova D, Blum AL, Talley NJ, Koelz HR. Will eradication of Helicobacter pylori improve symptoms of non-ulcer dyspepsia? Meta-analysis included unreliable studies. Br Med J. 2000; 320:1209.
     View PubMed
496. Boyce P, Gilchrist J, Talley NJ, Rose D. Cognitive-behavioural therapy as a treatment for irritable bowel syndrome; a pilot study. Australian and New Zealand Journal of Psychiatry. 2000; 34:300-9.
     View PubMed
497. Boyce PM, Koloski NA, Talley NJ. Irritable bowel syndrome according to varying diagnostic criteria: are the new Rome II criteria unnecessarily restrictive for research and practice? Am J Gastroenterol. 2000; 95:3176-83.
     View PubMed
498. Thitiphuree S, Talley NJ. Esomeprazole, a new proton pump inhibitor: pharmacological characteristics and clinical efficacy. Int J Clin Pract. 2000; 54:537-41.
     View PubMed
499. Eslick GD, Talley NJ. Non-cardiac chest pain: squeezing the life out of the Australian healthcare system? Med J Aust. 2000; 173:233-4.
     View PubMed
500. Talley NJ. Empirical eradication therapy was better than endoscopy-based management for Helicobacter pylori infection and dyspepsia. ACP Journal Club. 2000; 132:46.
501. Westbrook JI, McIntosh JH, Talley NJ. The impact of dyspepsia definition on prevalence estimates: considerations for future researchers. Scand J Gastroenterol. 2000; 35:227-33.
     View PubMed
502. Talley NJ. Irritable bowel syndrome: practical management. Aust Fam Physician. 2000; 29:893-8.
     View PubMed
503. Hammer J, Talley NJ. Nonulcer dyspepsia. Curr Opin Gastroenterol. 1999 Nov; 15(6):492.
     View PubMed
504. Xia HH, Gallagher C, Hyde D, Talley NJ, Keane CT, O'Morain CA. Comparison between McCoy cell line and HeLa cell line for detecting Helicobacter pylori cytotoxicity: clinical and pathological relevance. Ital J Gastroenterol Hepatol. 1999 Nov; 31(8):663-8.
     View PubMed
505. Kalantar JS, Talley NJ. The effects of lottery incentive and length of questionnaire on health survey response rates: a randomized study. J Clin Epidemiol. 1999 Nov; 52(11):1117-22.
     View PubMed
506. Talley NJ, Verlinden M, Jones M. Validity of a new quality of life scale for functional dyspepsia: a United States multicenter trial of the Nepean Dyspepsia Index. Am J Gastroenterol. 1999 Sep; 94(9):2390-7.
     View PubMed
507. Eslick GD, Lim LL, Byles JE, Xia HH, Talley NJ. Association of Helicobacter pylori infection with gastric carcinoma: a meta-analysis. Am J Gastroenterol. 1999 Sep; 94(9):2373-9.
     View PubMed
508. van Zanten SJOV, Talley NJ, Bytzer P, Klein KB, Whorwell PJ, Zinsmeister AR. Design of treatment trials for functional gastrointestinal disorders. Gut. 1999 Sep; 45(Suppl 2):69-77.
509. Howell S, Talley NJ. Does fear of serious disease predict consulting behaviour amongst patients with dyspepsia in general practice? Eur J Gastroenterol Hepatol. 1999 Aug; 11(8):881-6.
     View PubMed
510. Oliveria SA, Christos PJ, Talley NJ, Dannenberg AJ. Heartburn risk factors, knowledge, and prevention strategies: a population-based survey of individuals with heartburn. Arch Intern Med. 1999 Jul 26; 159(14):1592-8.
     View PubMed
511. Talley NJ. Gastro-esophageal reflux disease in adults. How to treat. Australian Doctor. 1999 Jul 2.
512. Roberts RO, Jacobsen SJ, Reilly WT, Pemberton JH, Lieber MM, Talley NJ. Prevalence of combined fecal and urinary incontinence: a community-based study. J Am Geriatr Soc. 1999 Jul; 47(7):837-41.
     View PubMed
513. Locke GR 3rd, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ 3rd. Risk factors associated with symptoms of gastroesophageal reflux. Am J Med. 1999 Jun; 106(6):642-9.
     View PubMed
514. Meineche-Schmidt V, Talley NJ, Pap A, Kordecki H, Schmid V, Ohlsson L, Wahlqvist P, Wiklund I, Bolling-Sternevald E. Impact of functional dyspepsia on quality of life and health care consumption after cessation of antisecretory treatment: a multicentre 3-month follow-up study. Scand J Gastroenterol. 1999 Jun; 34(6):566-74.
     View PubMed
515. Talley NJ, Janssens J, Lauritsen K, Racz I, Bolling-Sternevald E. Eradication of Helicobacter pylori in functional dyspepsia: randomised double blind placebo controlled trial with 12 months' follow up. Br Med J. 1999 Mar 27; 318(7187):833-7.
516. Talley NJ, Haque M, Wyeth JW, Stace NH, Tytgat GN, Stanghellini V, Holtmann G, Verlinden M, Jones M. Development of a new dyspepsia impact scale: the Nepean Dyspepsia Index. Aliment Pharmacol Ther. 1999 Feb; 13(2):225-35.
     View PubMed
517. Bolin TD, Korman MG, Stanton R, Talley NJ, Newstead GL, Donnelly N, Hall W, Ho MT, Lapsley H. Positive cost effectiveness of early diagnosis of colorectal cancer. Colorectal Disease. 1999; 1:113-22.
518. Lam CM, Kennedy ML, Lubowski DZ, Talley NJ. Prevalence and risk factors for faecal incontinence: a population based study. Colorectal Disease. 1999; 1:197-203.
519. Talley NJ, Vakil N, Ballard ED, Fennerty MB. Absence of benefit of eradicating Helicobacter pylori in patients with non-ulcer dyspepsia. N Engl J Med. 1999; 341:1106-11.
     View PubMed
520. Talley NJ. Irritable bowel syndrome: definition, diagnosis and epidemiology. Baillieres Clinical Gastroenterology International Practice and Research. 1999; 13:371-84.
521. Xia HH, Talley NJ. Helicobacter pylori eradication in patients with non-ulcer dyspepsia. Drugs. 1999; 58:785-92.
     View PubMed
522. Xia HH, Fan X-G, Talley NJ. Clarithromycin resistance in Helicobacter pylori and its clinical relevance. World Journal of Gastroenterology. 1999; 5:263-6.
     View PubMed
523. Talley NJ, Axon A, Bytzer P, Holtmann G, Lam SK, Veldhuyzen van Zanten S. Management of uninvestigated and functional dyspepsia: a working party report for the World Congresses of Gastroenterology 1998. Aliment Pharmacol Ther. 1999; 13:1135-48.
     View PubMed
524. Talley NJ. How should Helicobacter pylori positive dyspeptic patients be managed? Gut. 1999; 45(Suppl 1):I28-31.
     View PubMed
525. Talley NJ. Management of dyspepsia and functional dyspepsia: an international perspective. Canadian Journal of Gastroenterology. 1999; 13:685-7.
     View PubMed
526. Haag S, Nandurkar S, Talley NJ. Regression of Barrett's esophagus: the role of acid suppression, surgery, and ablative methods. Gastrointestinal Endoscopy. 1999; 50:229-40.
     View PubMed
527. Tytgat G, Hungin APS, Malfertheiner P, Talley NJ, Hongo M, McColl K, Soule JC, Agreus L, Bianchi-Porro G, Freston J, Hunt R. Decision making in dyspepsia: controversies in primary and secondary care. Eur J Gastroenterol Hepatol. 1999; 11:223-30.
     View PubMed
528. Talley NJ, Stanghellini V, Heading R, Koch KL, Malagelada JR, Tytgat GNJ. Functional gastroduodenal disorders: a working team report for the Rome II consensus on funtional gastrointestinal disorders. Gut. 1999; 45(Suppl 2):II37-42.
     View PubMed
529. Talley NJ, Wingate DL. Irritable bowel syndrome and the role of 5-HT. Aliment Pharmacol Ther. 1999; 13(Suppl 2):1-82.
530. Hammer J, Talley NJ. Diagnostic criteria for the irritable bowel syndrome. Am J Med. 1999; 107(Suppl 5A):5S-11S.
     View PubMed
531. Talley NJ. Helicobacter pylori and dyspepsia. Yale Journal of Biology and Medicine. 1999; 72:145-51.
     View PubMed
532. Dent J, Brun J, Fendrick AM, Fennerty MB, Janssens J, Kahrilas PJ, Lauritsen K, Reynolds JC, Shaw M, Talley NJ. An evidence-based appraisal of reflux disease management: the Genval workshop report. Gut. 1999; 44(Suppl 2):S1-S16.
     View PubMed
533. Nandurkar S, Talley NJ. Barrett's esophagus: the long and the short of it. Am J Gastroenterol. 1999; 94:1719.
     View PubMed
534. Mackender D, Talley NJ. Cutaneous signs of systemic disease. Current Therapeutics Part. 1999 Jul 1.
535. Mackender D, Talley NJ. Cutaneous signs of systemic disease. Current Therapeutics Part. 1999 Jul 2.
536. Mackender D, Talley NJ. Cutaneous signs of systemic disease. Current Therapeutics Part. 1999 Jul 3.
537. Yeomans N, Talley NJ, Lee A, Katelaris P. Helicobacter pylori: Guidelines for health care providers. Australian Gastroenterology Institute. 1999.
538. Kalantar J, Eslick G, Talley NJ. Chronic gastritis and non-ulcer dyspepsia. Curr Top Microbiol Immunol. 1999; 241:31-45.
     View PubMed
539. Blum AL, Talley NJ, O'Morain C, Veldhuyzen van Zanten SV, Labenz J, Stolte M, Louw JA, Stubberod A, Theodors A, Sundin M, Bolling-Sternevald E, Junghard O. Lack of effect of treating Helicobacter pylori infection in patients with non-ulcer dyspepsia. N Engl J Med. 1998 Dec 24; 339(26):1875-81.
     View PubMed
540. Bensoussan A, Talley NJ, Hing M, Menzies R, Guo A, Ngu M. Treatment of irritable bowel syndrome with Chinese herbal medicine: a randomized controlled trial. JAMA. 1998 Nov 11; 280(18):1585-9.
     View PubMed
541. Shaw M, Talley NJ, Adlis S, Beebe T, Tomshine P, Healey M. Development of a digestive health status instrument: tests of scaling assumptions, structure and reliability in a primary care population. Aliment Pharmacol Ther. 1998 Nov; 12(11):1067-78.
     View PubMed
542. Talley NJ, Meineche-Schmidt V, Pare P, Duckworth M, Raisanen P, Pap A, Kordecki H, Schmid V. Efficacy of omeprazole in functional dyspepsia: double-blind, randomized, placebo-controlled trials (the Bond and Opera studies). Aliment Pharmacol Ther. 1998 Nov; 12(11):1055-65.
     View PubMed
543. Talley NJ, Jones M. Self-reported rectal bleeding in a United States community: prevalence, risk factors, and health care seeking. Am J Gastroenterol. 1998 Nov; 93(11):2179-83.
     View PubMed
544. Kato M, Kephart GM, Talley NJ, Wagner JM, Sarr MG, Bonno M, McGovern TW, Gleich GJ. Eosinophil infiltration and degranulation in normal human tissue. Anat Rec. 1998 Nov; 252(3):418-25.
     View PubMed
545. Xia HH, Kalantar J, Talley NJ. Metronidazole- and clarithromycin-resistant Helicobacter pylori in dyspeptic patients in Western Sydney as determined by testing multiple isolates from different gastric sites. J Gastroenterol Hepatol. 1998 Oct; 13(10):1044-9.
     View PubMed
546. Nandurkar S, Martin CJ, Talley NJ, Wyatt JM. Curable cancer in a short segment Barrett's esophagus. Dis Esophagus. 1998 Oct; 11(4):284-7.
     View PubMed
547. Komoto K, Haruma K, Kamada T, Tanaka S, Yoshihara M, Sumii K, Kajiyama G, Talley NJ. Helicobacter pylori infection and gastric neoplasia: correlations with histological gastritis and tumor histology. Am J Gastroenterol. 1998 Aug; 93(8):1271-6.
     View PubMed
548. Morris-Yates A, Talley NJ, Boyce PM, Nandurkar S, Andrews G. Evidence of a genetic contribution to functional bowel disorder. Am J Gastroenterol. 1998 Aug; 93(8):1311-7.
     View PubMed
549. Holtmann G, Talley NJ, Mitchell H, Hazell S. Antibody response to specific H. pylori antigens in functional dyspepsia, duodenal ulcer, and health. Am J Gastroenterol. 1998 Aug; 93(8):1222-7.
     View PubMed
550. Nandurkar S, Talley NJ, Xia H, Mitchell H, Hazel S, Jones M. Dyspepsia in the community is linked to smoking and aspirin use but not Helicobacter pylori. Arch Intern Med. 1998 Jul 13; 158(13):1427-33.
     View PubMed
551. Talley NJ, Lambert JR, Howell S, Xia HH, Lin SK, Agreus L. An evaluation of whole blood testing for Helicobacter pylori in general practice. Aliment Pharmacol Ther. 1998 Jul; 12(7):641-5.
     View PubMed
552. Talley NJ, Chang FY, Wyatt JM, Adams S, Lau A, Borody T, Chen TS, Daskolopolos G, Cheung K, Talley NA, Full-Young C, Tseng-Shing C. Nizatidine in combination with amoxycillin and clarithromycin in the treatment of Helicobacter pylori infection. Aliment Pharmacol Ther. 1998 Jun; 12(6):527-32.
     View PubMed
553. Wiklund I, Glise H, Jerndal P, Carlsson J, Talley NJ. Does endoscopy have a positive impact on quality of life in dyspepsia? Gastrointest Endosc. 1998 Jun; 47(6):449-54.
     View PubMed
554. Talley NJ, Boyce P, Jones M. Dyspepsia and health care seeking in a community: how important are psychological factors? Dig Dis Sci. 1998 May; 43(5):1016-22.
     View PubMed
555. Talley NJ, Boyce P, Jones M. Identification of distrinct upper and lower gastrointestinal symptom groupings in an urban population. Gut. 1998 May; 42(5):690-5.
     View PubMed
556. Holtmann G, Goebell H, Jockenhoevel F, Talley NJ. Altered vagal and intestinal mechanosensory function in chronic unexplained dyspepsia. Gut. 1998 Apr; 42(4):501-6.
     View PubMed
557. Roberts RO, Jacobsen SJ, Rhodes T, Reilly WT, Girman CJ, Talley NJ, Lieber MM. Urinary incontinence in a community-based cohort: prevalence and healthcare-seeking. J Am Geriatr Soc. 1998 Apr; 46(4):467-72.
     View PubMed
558. Roberts RO, Jacobsen SJ, Jacobson DJ, Reilly WT, Talley NJ, Lieber MM. Natural history of prostatism: high American Urological Association Symptom scores among community-dwelling men and women with urinary incontinence. Urology. 1998 Feb; 51(2):213-9.
     View PubMed
559. Evans JM, Fleming KC, Talley NJ, Schleck CD, Zinsmeister AR, Melton LJ III. Relation of colonic transit to functional bowel disease in older people: a population-based study. J Am Geriatr Soc. 1998 Jan; 46(1):83-7.
     View PubMed
560. Talley NJ, Boyce PM, Jones M. Is the association between irritable bowel syndrome and abuse explained by neuroticism? A population-based study. Gut. 1998 Jan; 42(1):47-53.
     View PubMed
561. Junghard O, Lauritsen K, Talley NJ, Wiklund IK. Validation of seven graded diary cards for severity of dyspeptic symptoms in patients with non ulcer dyspepsia. Eur J Surg Suppl. 1998; 583:106-11.
     View PubMed
562. Niec AM, Frankum B, Talley NJ. Are adverse food reactions linked to irritable bowel syndrome? Am J Gastroenterol. 1998; 93:2184-90.
     View PubMed
563. Talley NJ, Eslick GD. Commentary on "Eradication of Helicobacter pylori before NSAID treatment prevented ulcers.". ACP Journal Club. 1998; 128:44.
564. Talley NJ. Commentary on review: Misoprostol was most cost-effective if risk for NSAID-related GI events was high. Arthritis Rheum. 1998; 129:25.
565. Nandurkar S, Talley NJ. Surveillance in Barrett's esophagus: a need for reassessment? J Gastroenterol Hepatol. 1998; 13:1069-105.
     View PubMed
566. Talley NJ. Healing of nonsteroidal anti-inflammatory drug-associated ulcers and erosions, and relief of dyspeptic symptoms: a commentary on the new data. Am J Med. 1998; 104:S62-6.
     View PubMed
567. Talley NJ. Scope of the problem of functional digestive disorders. European Journal of Surgery. 1998; 164(Suppl 582):135-41.
568. Talley NJ. Irritable bowel syndrome: disease definition and symptom description. Eur J Surg. 1998; 164(Suppl 583):24-8.
569. Talley NJ, Silverstein M, Agreus L, Nyrén O, Sonnenberg A, Holtmann G. AGA technical review-evaluation of dyspepsia. Gastroenterology. 1998; 114:582-95.
     View PubMed
570. Lam SK, Talley NJ. Report of the 1997 Asia Pacific Consensus guidelines on the management of H. pylori. J Gastroenterol Hepatol. 1998; 13:1-12.
     View PubMed
571. Talley NJ, Hau-Xiang Xia H. Helicobacter pylori infection and non-ulcer dyspepsia. British Medical Bulletin. 1998; 54:63-9.
     View PubMed
572. Xia HH, Talley NJ. Helicobacter pylori infection, reflux esophagitis, and atrophic gastritis: an unexplored triangle. Am J Gastroenterol. 1998; 93:394-400.
     View PubMed
573. Veldhuyzen van Zanten S, Talley NJ. Should antibiotic treatment of Helicobacter positive patients within non-ulcer dyspepsia now be recommended? Eur J Gastroenterol Hepatol. 1998; 10:367-70.
     View PubMed
574. Hu WHC, Talley NJ. Functional (non-ulcer) dyspepsia: unexplained but not unmanageable. Med J Aust. 1998; 168:507-12.
     View PubMed
575. Hammer J, Talley NJ. Non-ulcer dyspepsia: evaluation (including the role of Helicobacter pylori, the role of dysmotility, and management). Curr Opin Gastroenterol. 1998; 14:447-51.
576. Weltmann M, Talley NJ. The patient with recurrent non-identifiable GI bleeding. Current Therapeutics. 1998.
577. Wiklund IK, Junghard O, Grace E, Talley NJ, Kamm M, Veldhuyzen van Zanten S, Pare P, Chiba N, Leddin DS, Bigard MA, Colin R, Schoenfeld P. Quality of Life in Reflux and Dyspepsia patients. Psychometric documentation of a new disease-specific questionnaire (QOLRAD). Eur J Surg Suppl. 1998; (583):41-9.
578. Phung N, Kalantar J, Talley NJ. Management of dyspepsia in general practice. Mod Med. 1998; 41:10-18.
579. Talley NJ, O'Connor S. Sistema nervioso: exploracion de los nervios craneales (III). Review Salud Rural. 1998; 5:111-30.
580. Talley NJ, Kalantar JS. Unexplained weight loss. Curr Ther. 1998; 37-43.
581. Holtmann G, Stanghellini V, Talley NJ. Nomenclature of dyspepsia, dyspepsia subgroups and functional dyspepsia: clarifying the concepts. Baillieres Clin Gastroenterol. 1998; 12:417-33.
     View PubMed
582. Kalantar SJ, Marks R, Lambert JR, Badov D, Talley NJ. Dyspepsia due to eosinophilic gastroenteritis. Dig Dis Sci. 1997 Nov; 42(11):2327-32.
     View PubMed
583. Talley NJ, Boyce PM, Jones M. Predictors of health care seeking for irritable bowel syndrome: a population-based study. Gut. 1997 Sep; 41(3):394-8.
     View PubMed
584. Talley NA, Chen F, King D, Jones M, Talley NJ. Short chain fatty acids in the treatment of radiation proctitis: a randomized, placebo-controlled crossover trial. Dis Colon Rectum. 1997 Sep; 40(9):1046-50.
     View PubMed
585. Nandurkar S, Talley NJ, Martin CJ, Ng THK, Adams S. Short segment Barrett's oesophagus: prevalence, diagnosis, and associations. Gut. 1997 Jun; 40(6):710-5.
     View PubMed
586. Holtmann G, Goebell H, Talley NJ. Functional dyspepsia and irritable bowel syndrome: is there a common pathophysiological basis? Am J Gastroenterol. 1997 Jun; 92(6):954-9.
     View PubMed
587. Friedrich WN, Talley NJ, Panser L, Fett S, Zinsmeister AR. Concordance of reports of childhood abuse by adults. Child Maltreat. 1997 May; 2(2):164-71.
588. Locke GR III, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ III. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology. 1997 May; 112(5):1448-56.
     View PubMed
589. Frankum B, Talley NJ. The tired listless patient. Curr Ther. 1997 Mar; 41-5.
590. Talley NJ, Xia HH. Gastric cancer. An infectious disease? New Zealand Patient Management. 1997; 26:9-11.
591. Agreus L, Talley NJ. Dyspepsia: current understanding and management. Annual Review Medicine. 1997; 49:475-93.
592. Agreus L, Talley N. Dyspepsia management in general practice. Br Med J. 1997; 315:1284-8.
593. McManis PG, Talley NJ. Nausea and vomiting associated with selective serotonin reuptake inhibitors: incidence, mechanisms, and management. CNS Drugs. 1997; 8:394-401.
594. Xia HH, Talley NJ, Keane CT, O'Morain CA. Recurrence of Helicobacter pylori infection after successful eradication: nature, possible causes, and potential preventive strategies. Dig Dis Sci. 1997; 42:1821-34.
     View PubMed
595. Xia HH, Talley NJ. Natural acquisition and spontaneous elimination of Helicobacter pylori infection: clinical implications. Am J Gastroenterol. 1997; 92:1780-7.
     View PubMed
596. Talley NJ, Hunt RH. What role does Helicobacter pylori play in non-ulcer dyspepsia? Arguments for and against H. pylori being associated with dyspeptic symptoms Gastroenterology. 1997; 113(6 Suppl S):S67-77.
597. Talley NJ. Dyspepsia and heartburn: a clinical challenge. Aliment Pharmacol Ther. 1997; 11(Suppl 2):1-8.
598. Holtmann G, Talley NJ, Goebell H. Association between Helicobacter pylori, duodenal mechanosensory thresholds, and small intestinal motility in chronic unexplained dyspepsia. Dig Dis Sci. 1996 Jul; 41(7):1285-91.
     View PubMed
599. Loy C, Irwig L, Katelaris PH, Talley NJ. Do commercial serological kits for Helicobacter pylori infection differ in accuracy?: a meta-analysis. Am J Gastroenterol. 1996 Jun; 91(6):1138-44.
     View PubMed
600. Veldhuyzen van Zanten SJ, Cleary C, Talley NJ, Peterson TC, Nyren O, Bradley LA, Verlinden M, Tytgat GN. Drug treatment of functional dyspepsia: a systematic analysis of trial methodology with recommendations for the design of future trials. Am J Gastroenterol. 1996 Apr; 91(4):660-73.
     View PubMed
601. Holtmann G, Goebell H, Talley NJ. Impaired small intestinal peristaltic reflexes and sensory thresholds are independent functional disturbances in patients with chronic unexplained dyspepsia. Am J Gastroenterol. 1996 Mar; 91(3):485-91.
     View PubMed
602. Toma TP, Zighelboim J, Phillips SF, Talley NJ. Methods for studying intestinal sensitivity and compliance: in vitro studies of balloons and a barostat. Neurogastroenterol Motil. 1996 Mar; 8(1):19-28.
     View PubMed
603. Talley NJ, Hu WHC. Commentary on "Misoprostol reduced serious NSAID-induced gastrointestinal complications in rheumatoid arthritis.". Ann Intern Med. 1996 Mar-Apr; 124:38.
604. Talley NJ, Owen BK, Boyce P, Paterson K. Psychological treatment for irritable bowel syndrome: a critique of controlled treatment trials. Am J Gastroenterol. 1996 Feb; 91(2):277-83.
     View PubMed
605. Silverstein MD, Petterson T, Talley NJ. Initial endoscopy or empirical therapy with or without testing for Helicobacter pylori for dyspepsia: a decision analysis. Gastroenterology. 1996 Jan; 110(1):72-83.
     View PubMed
606. Talley NJ, Fleming KC, Evans JM, O'Keefe EA, Weaver AL, Zinsmeister AR, Melton LJ. Constipation in an elderly community: a study of prevalence and potential risk factors. Am J Gastroenterol. 1996 Jan; 91(1):19-25.
     View PubMed
607. Talley NJ. Modern management of dyspepsia. Aust Fam Physician. 1996; 25:47-52.
     View PubMed
608. Hu WHC, Talley NJ. Visceral perception in functional gastrointestinal disorders: disease marker or epiphenomenon? Dig Dis. 1996; 4:276-88.
609. Talley NJ. Quality of life in functional dyspepsia. Scand J Gastroenterol. 1996; 31(Suppl 221):21-2.
610. Talley NJ. Helicobacter pylori and non-ulcer dyspepsia. Scand J Gastroenterol. 1996; 31(Suppl 220):19-22.
611. Xia HH, Talley NJ. Prospects for improved therapy for Helicobacter pylori. (Leading Article). Expert Opin Investig Drugs. 1996; 5:959-76.
612. Talley NJ. H. pylori and functional dyspepsia. Excepta Medica. 1996; 5-6.
613. Talley NJ. Helicobacter pylori: a role in functional dyspepsia? Motility Clinical Perspective in Gastroenterology. 1996; 34:11-12.
614. Talley NJ. The irritable bowel syndrome: the guts of the problem. Resident & Staff Physician. 1996; 42:11-16.
615. Talley NJ. Management of peptic ulcer disease. No role for long-term H2RAs. Gastrointestinal Medicine in General Practice. 1996; 8:22-5.
616. Talley NJ, Camilleri M. Epidemiological features of functional dyspepsia and irritable bowel syndrome. Clinican. 1996; 14:7-13.
617. Talley NJ. Is there a role for H2 -receptor blockers in the treatment of H. pylori gastritis? The Management of Acid Peptic Disorders: An Asian Perspective. 1996; 12:25-9.
618. Talley NJ. Irritable bowel syndrome. Australian Doctor. 1996.
619. Talley NJ, Hu WHC, Holtmann G. Symptoms, investigation and treatment of gastroparesis. Mod Med Aust. 1995 Dec; 27-33.
620. Locke GR III, Talley NJ, Carpenter HA, Harmsen WS, Zinsmeister AR, Melton J. Changes in the site- and histology-specific incidence of gastric cancer during a 50-year period. Gastroenterology. 1995 Dec; 109(6):1750-6.
     View PubMed
621. Talley NJ, Boyce P, Owen BK. Psychological distress and seasonal symptom changes in irritable bowel syndrome. Am J Gastroenterol. 1995 Dec; 90(12):2115-9.
     View PubMed
622. Drossman DA, Talley NJ, Leserman J, Olden KW, Barreiro MA. Sexual and physical abuse and gastrointestinal illness. Review and recommendations. Ann Intern Med. 1995 Nov 15; 123(10):782-94.
     View PubMed
623. Talley NJ, Boyce PM, Owen BK, Newman P, Paterson KJ. Initial validation of a bowel symptom questionnaire and measurement of chronic gastrointestinal symptoms in Australians. Aust N Z J Med. 1995 Aug; 25(4):302-8.
     View PubMed
624. Talley NJ, Zinsmeister AR, Melton LJ. Irritable bowel syndrome in a community: symptom subgroups, risk factors, and health care utilization. Am J Epidemiol. 1995 Jul 1; 142(1):76-83.
     View PubMed
625. O'Keefe EA, Talley NJ, Zinsmeister AR, Jacobsen SJ. Bowel disorders impair functional status and quality of life in the elderly: a population-based study. J Gerontol A Biol Sci Med Sci. 1995 Jul; 50(4):M184-9.
     View PubMed
626. Talley NJ, Evans JM, Fleming KC, Harmsen WS, Zinsmeister AR, Melton LJ 3rd. Nonsteroidal antiinflammatory drugs and dyspepsia in the elderly. Dig Dis Sci. 1995 Jun; 40(6):1345-50.
     View PubMed
627. Talley NJ, Hu WHC. Commentary on "Corticosteroids and peptic ulcer: meta-analysis of adverse events during steroid therapy.". Ann Intern Med. 1995 May-Jun; 122:81.
628. Zighelboim J, Talley NJ, Phillips SF, Harmsen WS, Zinsmeister AR. Visceral perception in irritable bowel syndrome. Rectal and gastric responses to distension and serotonin type 3 antagonism. Dig Dis Sci. 1995 Apr; 40(4):819-27.
     View PubMed
629. Talley NJ, Fett SL, Zinsmeister AR. Self-reported abuse and gastrointestinal disease in outpatients: association with irritable bowel-type symptoms. Am J Gastroenterol. 1995 Mar; 90(3):366-71.
     View PubMed
630. Talley NJ, Weaver AL, Zinsmeister AR. Impact on functional dyspepsia on quality of life. Dig Dis Sci. 1995 Mar; 40:584-589.
     View PubMed
631. Carpenter HA, Talley NJ. Gastroscopy is incomplete without biopsy: clinical relevance of distinguishing gastropathy from gastritis. Gastroenterology. 1995 Mar; 108(3):917-24.
     View PubMed
632. Talley NJ. Dyspepsia in the elderly. Mod Med Aust. 1995 Feb; 72-6.
633. Owens DM, Nelson DK, Talley NJ. Irritable bowel syndrome: long term prognosis and the physician-patient interaction. Ann Intern Med. 1995 Jan 15; 122(2):107-12.
     View PubMed
634. Zighelboim J, MacCarty RL, Talley NJ. Abnormalities in the shape of the duodenal loop on X-ray. Associated with idiopathic antral hypomotility? Dig Dis Sci. 1995 Jan; 40(1):128-33.
     View PubMed
635. Holtmann G, Guerra G, Huber J, Goebell H, Talley NJ. Perception of gastric distention: influence of the mode of distention on perception thresholds and gastric compliance. Dig Dis Sci. 1995; 40:2673-7.
     View PubMed
636. Bolin T, Hunt R, Korman M, Lambert J, Lee A, Talley NJ. Helicobacter pylori and gastric neoplasia: evolving concepts. Med J Aust. 1995; 163:253-25.
     View PubMed
637. Talley NJ. Functional dyspepsia: should treatment be targeted on disturbed physiology? Aliment Pharmacol Ther. 1995; 9:107-15.
     View PubMed
638. Talley NJ. Management of dyspepsia. Gastrointestinal Diseases Today. 1995; 4:11-17.
639. Lambert J, Lee A, Talley NJ, Yeomans N. Helicobacter pylori: Guidelines for health care providers. Australian Gastroenterology Institute. 1995.
640. Talley NJ, Fett SL, Zinsmeister AR, Melton LJ III. Gastrointestinal tract symptoms and self-reported abuse: a population-based study. Gastroenterology. 1994 Oct; 107(4):1040-9.
     View PubMed
641. Talley NJ, Weaver AL, Zinsmeister AR, Melton LJ III. Self-reported diarrhea: what does it mean? Am J Gastroenterol. 1994 Aug; 89(8):1160-4.
     View PubMed
642. Zighelboim J, Talley NJ, Phillips SF. Response of gastric fundus to rectal distension in healthy persons. Dig Dis Sci. 1994 Jul; 39(7):1441-5.
     View PubMed
643. Locke GR, Talley NJ, Weaver AL, Zinsmeister AR. A new questionnaire for gastroesophageal reflux disease. Mayo Clin Proc. 1994 Jun; 69(6):539-47.
     View PubMed
644. Talley NJ, Valdovinos M, Petterson TM, Carpenter HA, Melton LJ III. Epidemiology of celiac sprue: a community-based study. Am J Gastroenterol. 1994 Jun; 89(6):843-6.
     View PubMed
645. Grotz RL, Pemberton JH, Talley NJ, Rath DM, Zinsmeister AR. Discriminant value of psychological distress, symptom profiles, and segmental colonic dysfunction in outpatients with severe idiopathic constipation. Gut. 1994 Jun; 35(6):798-802.
     View PubMed
646. Talley NJ, Zinsmeister AR, Schleck CD, Melton LJ 3rd. Smoking, alcohol, and analgesics in dyspepsia and among dyspepsia subgroups: lack of an association in a community. Gut. 1994 May; 35(5):619-24.
     View PubMed
647. Talley NJ. A critique of therapeutic trials in Helicobacter pylori-positive functional dyspepsia. Gastroenterology. 1994 May; 106(5):1174-83.
     View PubMed
648. Holtmann G, Goebell H, Holtmann M, Talley NJ. Dyspepsia in healthy blood donors: pattern of symptoms and association with Helicobacter pylori. Dig Dis Sci. 1994 May; 39(5):1090-8.
     View PubMed
649. Holtmann G, Talley NJ. Functional dyspepsia. Current treatment recommendations. Curr Ther. 1994 May; 55-63.
650. Talley NJ, Weaver AL, Zinsmeister AR. Smoking, alcohol, and nonsteroidal anti-inflammatory drugs in outpatients with functional dyspepsia and among dyspepsia subgroups. Am J Gastroenterol. 1994 Apr; 89(4):524-8.
     View PubMed
651. Talley NJ. Epidemiology of Helicobacter pylori infection. NIH Consens Statement. 1994 Feb 7-9; 12:1-15.
652. Talley NJ. Diagnosis of Helicobacter pylori infection. Infections in Medicine. 1994; (Special Supplement):18-26.
653. Talley NJ. Food for thought: the real story behind stomach ulcers. Chem Ind. 1994; 7:259-62.
654. Holtmann G, Goebell H, Talley NJ. Dyspepsia in consulters and non-consulters: prevalence, health-care seeking behaviour and risk factors. European Journal of Gastroenterology and Hepatology. 1994; 6:917-24.
655. Talley NJ. A relationship between Helicobacter pylori and non-ulcer dyspepsia: is there enough data to know? Eur J Gastroenterol Hepatol. 1994; 6:567-70.
656. Talley NJ. Commentary on "Prompt endoscopy was more cost-effective than H2-blockers in dyspepsia.". Ann Intern Med. 1994; 121(Suppl 2).
657. Talley NJ. Gastroduodenal motility. Curr Opin Gastroenterol. 1994; 10:618-22.
658. Kim CH, Cameron AJ, Hsu JJ, Talley NJ, Trastek VF, Pairolero PC, O'Connor MK, Colwell LJ, Zinsmeister AR. Achalasia: prospective evaluation of relationship between lower esophageal sphincter pressure, esophageal transit, and esophageal diameter and symptoms in response to pneumatic dilation. Mayo Clin Proc. 1993 Nov; 68(11):1067-73.
     View PubMed
659. Talley NJ, Weaver AL, Tesmer DL, Zinsmeister AR. Lack of discriminant value of dyspepsia subgroups in patients referred for upper endoscopy. Gastroenterology. 1993 Nov; 105:1378-1386.
     View PubMed
660. Hammer J, Phillips SF, Talley NJ, Camilleri M. Effect of a 5HT3-antagonist (ondansetron) on rectal sensitivity and compliance in health and the irritable bowel syndrome. Alimentary Pharmacology & Therapeutics. 1993 Oct; 7(5):543-51.
     View PubMed
661. Talley NJ, Weaver AL, Zinsmeister AR, Melton LJ 3rd. Functional constipation and outlet delay: a population-based study. Gastroenterology. 1993 Sep; 105(3):781-90.
     View PubMed
662. Zighelboim J, Carpenter HA, Talley NJ. A patient with diarrhea, arthralgias, and fever. Gastroenterology. 1993 Sep; 105(3):923-30.
     View PubMed
663. Holtmann G, Talley NJ. Functional dyspepsia: current treatment recommendations. Drugs. 1993 Jun; 45(6):918-30.
     View PubMed
664. Talley NJ. Non-ulcer dyspepisa: current approaches to diagnosis and management. Am Fam Physician 1 1993 May; 47(6):1407-16.
665. Wolfsen HC, Carpenter HA, Talley NJ. Menetrier's disease: a form of hypertrophic gastropathy or gastritis? Gastroenterology. 1993 May; 104(5):1310-9.
     View PubMed
666. Locke GR, Talley NJ. Management of non-ulcer dyspepsia. J Gastroenterol Hepatol. 1993 May-Jun; 8(3):279-86.
     View PubMed
667. Zighelboim J, Talley NJ. Viewpoints in digestive diseases: what are functional bowel disorders? Gastroenterology. 1993 Apr; 104(4):1196-201.
     View PubMed
668. Talley NJ. The role of Helicobacter pylori in non-ulcer dyspepsia. Gastroenterol Clin North Am. 1993 Mar; 22:153-67.
     View PubMed
669. Thomas DW, Talley NJ, Mahnovski V, Haight M, Sinatra FR. Rectal mucosal major basic protein in infants with dietary protein-induced colitis. Annals of Allergy. 1993; 71:66-9.
     View PubMed
670. Drossman DA, Li Z, Andruzzi E, Temple RD, Talley NJ, Thompson WG, Whitehead WE, Janssens J, Funch-Jensen P, Corazziari E, Richter JE, Koch GG. U.S. householder survey of functional gastrointestinal disorders: prevalence, sociodemography, and health impact. Dig Dis Sci. 1993; 38:1569-80.
     View PubMed
671. Talley NJ, Kramlinger KG, Burton MC, Colwell LJ, Zinsmeister AR. Psychiatric disorders and childhood abuse in the irritable bowel syndrome. Eur J Gastroenterol Hepatol. 1993; 5:647-54.
672. Talley NJ, Nyren O, Drossman DA, Heaton KW, Veldhuyzen van Zanten SJO, Koch MM, Ransohoff DF. The irritable bowel syndrome: toward optimal design of controlled treatment trials. Gastroenterology International. 1993; 6:189-211.
673. Talley NJ. Commentations on "Cholecystectomy and the risk for colorectal cancer.". Ann Intern Med. 1993; 120(Suppl 1).
674. Talley NJ. The effects of NSAIDs on the gut. Contemp Intern Med. 1993; 5:14-28.
675. Talley NJ. Non-steroidal anti-inflammatory drug-induced gatroduodenopathy. Dear Colleague. 1993.
676. Miralles GD, O'Fallon JR, Talley NJ. Plasma-cell dyscrasia with polyneuropathy. The spectrum of POEMS syndrome. N Engl J Med. 1992 Dec 31; 327(27):1919-23.
     View PubMed
677. Talley NJ, Kost L, Haddad A, Zinsmeister AR. Comparison of commercial serological tests for detection of Helicobacter pylori antibodies. J Clin Microbiol. 1992 Dec; 30(12):3146-50.
     View PubMed
678. Vassallo MJ, Camilleri M, Phillips SF, Steadman CJ, Talley NJ, Hanson RB, Haddad AC. Colonic tone and motility in patients with irritable bowel syndrome. Mayo Clin Proc. 1992 Aug; 67(8):725-31.
     View PubMed
679. Steadman CJ, Talley NJ, Phillips SF, Zinsmeister AR. Selective 5-hydroxytryptamine type 3 receptor antagonism with ondansetron as treatment for diarrhea-predominant irritable bowel syndrome: a pilot study. Mayo Clin Proc. 1992 Aug; 67(8):732-8.
     View PubMed
680. Talley NJ. Symptom patterns in functional dyspepsia. Eur J Gastroenterol Hepatol. 1992 Aug; 4:597-601.
681. Talley NJ, Weaver AL, Zinsmeister AR, Melton LJ 3rd. Onset and disappearance of gastrointestinal symptoms and functional gastrointestinal disorders. Am J Epidemiol. 1992 Jul 15; 136(2):165-77.
     View PubMed
682. O'Keefe EA, Talley NJ, Tangalos EG, Zinsmeister AR. A bowel symptom questionnaire for the elderly. J Gerontol. 1992 Jul; 47(4):M116-21.
     View PubMed
683. Talley NJ, Kephart GM, McGovern TW, Carpenter HA, Gleich GJ. Deposition of eosinophil granule major basic protein in eosinophilic gastroenteritis and celiac disease. Gastroenterology. 1992 Jul; 103(1):137-45.
     View PubMed
684. Loeb DS, Talley NJ, Ahlquist DA, Carpenter HA, Zinsmeister AR. Long-term nonsteroidal anti-inflammatory drug use and gastroduodenal injury: the role of Helicobacter pylori. Gastroenterology. 1992 Jun; 102(6):1899-905.
     View PubMed
685. Talley NJ, Ormand JE, Frie CA, Zinsmeister AR. Stability of pH gradients in vivo across the stomach in Helicobacter pylori gastritis, dyspepsia, and health. Am J Gastroenterol. 1992 May; 87(5):590-4.
     View PubMed
686. Steadman CJ, Phillips SF, Camilleri M, Talley NJ, Haddad A, Hanson R. Control of muscle tone in the human colon. Gut. 1992 Apr; 33(4):541-6.
     View PubMed
687. Loeb DS, Ahlquist DA, Talley NJ. Management of gastroduodenopathy associated with use of nonsteroidal anti-inflammatory drugs. Mayo Clin Proc. 1992 Apr; 67(4):354-64.
     View PubMed
688. Talley NJ, Zinsmeister AR, Schleck CD, Melton LJ 3rd. Dyspepsia and dyspepsia subgroups: a population-based study. Gastroenterology. 1992 Apr; 102(4 Pt 1):1259-68.
     View PubMed
689. Talley NJ, O'Keefe EA, Zinsmeister AR, Melton LJ III. Prevalence of gastrointestinal symptoms in the elderly: a population-based study. Gastroenterology. 1992 Mar; 102:895-901.
     View PubMed
690. Talley NJ. 5-Hydroxytryptamine agonists and antagonists in the modulation of gastrointestinal motility and sensation: clinical implications. Aliment Pharmacol Ther. 1992; 6:273-89.
     View PubMed
691. Talley NJ. Dyspepsia and functional dyspepsia. Clin Perspect Gastroenterol. 1992; 20:4-8.
692. Talley NJ. Helicobacter pylori infection. Decision Making in GI Disease. 1992; 5:1-8.
693. Talley NJ, Zinsmeister AR, Weaver A, DiMagno EP, Carpenter HA, Perez-Perez GI, Blaser MJ. Gastric adenocarcinoma and Helicobacter pylori infection. J Natl Cancer Inst. 1991 Dec 4; 83(23):1734-9.
     View PubMed
694. Talley NJ, Zinsmeister AR, Van Dyke C, Melton LJ 3rd. Epidemiology of colonic symptoms and the irritable bowel syndrome. Gastroenterology. 1991 Oct; 101(4):927-34.
     View PubMed
695. Talley NJ, Newell DG, Ormand JE, Carpenter HA, Wilson WR, Zinsmeister AR, Perez-Perez GI, Blaser MJ. Serodiagnosis of Helicobacter pylori: comparison of enzyme-linked immunosorbent assays. J Clin Microbiol. 1991 Aug; 29(8):1635-9.
     View PubMed
696. O'Keefe E, Talley NJ. The irritable bowel syndrome in the elderly. Gastroenterol Clin North Am. 1991 Jun; 20:369-90.
697. O'Keefe E, Talley NJ. Irritable bowel syndrome in the elderly. Clin Geriatr Med. 1991 May; 7(2):265-86.
     View PubMed
698. McGovern TW, Talley NJ, Kephart GM, Carpenter HA, Gleich GJ. Eosinophil infiltration and degranulation in Helicobacter pylori-associated chronic gastritis. Dig Dis Sci. 1991 Apr; 36(4):435-40.
     View PubMed
699. Ormand JE, Talley NJ, Shorter RG, Conley CR, Carpenter HA, Fich A, Wilson WR, Phillips SF. Prevalence of Helicobacter pylori in specific forms of gastritis: further evidence supporting a pathogenic role for H. pylori in chronic nonspecific gastritis. Dig Dis Sci. 1991 Feb; 36:142-145.
     View PubMed
700. Talley NJ, Phillips SF, Bruce BK, Zinsmeister AR, Wiltgen C, Melton LJ. Multisystem complaints in patients with the irritable bowel syndrome and functional dyspepsia. Eur J Gastroenterol Hepatol. 1991 Jan; 3:71-77.
701. Fich A, Talley NJ, Shorter RG, Phillips SF. Zollinger-Ellison syndrome. Relation to Helicobacter pylori-associated chronic gastritis and gastric acid secretion. Dig Dis Sci. 1991 Jan; 36(1):10-4.
     View PubMed
702. Myers MB, Miralles GD, Taylor CA, Gastineau DA, Pisani RJ, Talley NJ. POEMS syndrome with idiopathic flushing mimicking cardinoid syndrome. Am J Med. 1991; 90:646-648.
     View PubMed
703. Smith RC, Talley NJ, Dent OF, Jones M, Waller SL. Exocrine pancreatic function and chronic unexplained dyspepsia. A case control study. International Journal of Pancreatology. 1991; 8:253-62.
     View PubMed
704. Talley NJ, Colin-Jones D, Koch KL, Koch M, Nyren O, Stanghellini V. Functional dyspepsia: a classification with guidelines for diagnosis and management. Gastroenterology International. 1991; 4:145-60.
705. Tygat GNJ, Heading RC, Knill-Jones RP, Richter JE, Malagelada JR, Nyren O, Talley NJ. Towards understanding dyspepsia: an update and consensus from an international working party. Scand J Gastroenterol. 1991; 26(Suppl 182):1-74.
706. Talley NJ. Drug treatment of functional dyspepsia. Scand J Gastroenterol. 1991; 26(Suppl 182):47-60.
707. Talley NJ. Spectrum of chronic dyspepsia in the prescence of the irritable bowel syndrome. Scand J Gastroenterol. 1991; 26(Suppl 182):7-10.
708. Talley NJ. Non-ulcer dyspepsia: myths and realities. Aliment Pharmacol Ther. 1991; 5 (Suppl 1):145-62.
     View PubMed
709. Drossman DA, Thompson WG, Talley NJ, Funch-Jensen P, Janssens J, Whitehead WE. Identification of sub-groups of functional gastrointestinal disorders. Gastroenterology International. 1990 Dec; 3:159-172.
710. Talley NJ, Phillips SF, Wiltgen CM, Zinsmeister AR, Melton LJ 3rd. Assessment of functional gastrointestinal disease: the bowel disease questionnaire. Mayo Clin Proc. 1990 Nov; 65(11):1456-79.
     View PubMed
711. Talley NJ, Phillips SF, Bruce B, Twomey CK, Zinsmeister AR, Melton LJ 3rd. Relation among personality and symptoms in nonulcer dyspepsia and the irritable bowel syndrome. Gastroenterology. 1990 Aug; 99(2):327-33.
     View PubMed
712. Ormand JE, Talley NJ, Carpenter HA, Shorter RG, Conley CR, Wilson WR, DiMagno EP, Zinsmeister AR, Phillips SF. [14C]urea breath test for diagnosis of Helicobacter pylori. Dig Dis Sci. 1990 Jul; 35(7):879-84.
     View PubMed
713. MacCarty RL, Talley NJ. Barium studies in diffuse eosinophilic gastroenteritis. Gastrointest Radiol. 1990 Summer; 15(3):183-7.
     View PubMed
714. Talley NJ, Phillips SF, Haddad A, Miller LJ, Twomey C, Zinsmeister AR, MacCarty RL, Ciociola A. GR 38032F (ondansetron), a selective 5HT3 receptor antagonist, slows colonic transit in healthy man. Dig Dis Sci. 1990 Apr; 35(4):477-80.
     View PubMed
715. Ormand JE, Talley NJ. Helicobacter pylori: controversies and an approach to management. Mayo Clin Proc. 1990 Mar; 65(3):414-26.
     View PubMed
716. Fich A, Talley NJ, Shorter RG, Phillips SF. Does Helicobacter pylori colonize the gastric mucosa of Meckel's diverticulum? Mayo Clin Proc. 1990 Feb; 65(2):187-91.
     View PubMed
717. Talley NJ, Shorter RG, Phillips SF, Zinsmeister AR. Eosinophilic gastroenteritis: a clinicopathological study of patients with disease of the mucosa, muscle layer, and subserosal tissues. Gut. 1990 Jan; 31(1):54-8.
     View PubMed
718. Talley NJ, Phillips SF, Melton LJ, Mulvihill C, Wiltgen C, Zinsmeister AR. Diagnostic value of the Manning criteria in irritable bowel syndrome. Gut. 1990 Jan; 31(1):77-81.
     View PubMed
719. Talley NJ. A practical approach to dyspepsia. Contemp Intern Med. 1990; 25-33.
720. Talley NJ. Helicobacter pylori and chronic gastroduodenal disease. Infectious Diseases Newsletter. 1990; 9:65-7.
721. Pym B, Sandstad J, Seville P, Byth K, Middleton WRJ, Talley NJ, Piper DW. Cost-effectiveness of cimetidine maintenance therapy in chronic gastric and duodenal ulcer. Gastroenterology. 1990; 99:27-35.
     View PubMed
722. Talley NJ, Chute CG, Larson DE, Epstein R, Lydick EG, Melton LJ 3rd. Risk for colorectal adenocarcinoma in pernicious anemia. A population-based cohort study. Ann Intern Med. 1989 Nov 1; 111(9):738-42.
     View PubMed
723. Talley NJ, Phillips SF, Melton J 3rd, Wiltgen C, Zinsmeister AR. A patient questionnaire to identify bowel disease. Ann Intern Med. 1989 Oct 15; 111(8):671-4.
     View PubMed
724. Talley NJ, Camilleri M, Orkin BA, Kramlinger KG. Effect of cyclical unipolar depression on upper gastrointestinal motility and sleep. Gastroenterology. 1989 Sep; 97(3):775-7.
     View PubMed
725. Talley NJ, Phillips SF, Haddad A, Miller LJ, Twomey C, Zinsmeister AR, Ciociola A. Effect of a selective 5HT3 antagonist (GR-38032F) on small intestinal transit and release of gastrointestinal peptides. Dig Dis Sci. 1989; 34:1511-1515.
     View PubMed
726. Talley NJ. Chronic (nonerosive) gastritis: pathogenesis and management. Dig Dis. 1989; 7(2):61-75.
     View PubMed
727. Talley NJ, Shuter B, McCrudden G, Jones M, Hoschl R, Piper DW. Lack of association between gastric emptying of solids and symptoms in non-ulcer dyspepsia. J Clin Gastroenterol. 1989; 11:625-30.
     View PubMed
728. Ormand JE, Talley NJ. Campylobacter pylori, mucus, and peptic ulceration: a dynamic interaction. J Clin Gastroenterol. 1989; 11:492-5.
     View PubMed
729. Talley NJ, Ormand JE. Is antibacterial therapy against Campylobacter pylori useful in the therapy of indigestion and chronic peptic ulceration? Trends in Pharmacological Sciences. 1989; 10:36-40.
     View PubMed
730. Talley NJ, Kellow JE, Piper DW. Non-ulcer dyspepsia: a management plan. Curr Ther. 1989; 30:91-103.
731. Talley NJ. Upper gastrointestinal distress: guidelines for empirical treatment and investigation. Med Times. 1989; 117:25-8.
732. Talley NJ. Campylobacter pylori and chronic peptic ulceration: do bugs cause ulcers? Asociacion de Medicina Interna de Mexico, AC. Clinicas Medicas Mexicanas. Curso Internacional de Medicina Interna. 1989; 3:5-7.